Conceptus-Derived Immunosuppressive Factors and Their Role in Fetal Allograft Protection. by Roth, Terri Lynn
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1991
Conceptus-Derived Immunosuppressive Factors
and Their Role in Fetal Allograft Protection.
Terri Lynn Roth
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Roth, Terri Lynn, "Conceptus-Derived Immunosuppressive Factors and Their Role in Fetal Allograft Protection." (1991). LSU
Historical Dissertations and Theses. 5207.
https://digitalcommons.lsu.edu/gradschool_disstheses/5207
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may 
be from any type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand corner and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in 
reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order.
University Microfilms International  
A Beil & Howell  Information C o m p a n y  
3 0 0  North Z e e b  Road ,  Ann Arbor, Ml 4 8 1 0 6 - 1 3 4 6  USA  
3 1 3 / 7 6 1 - 4 7 0 0  8 0 0 / 5 2 1 - 0 6 0 0

Order Number 9207529
C onceptus-derived im m unosuppressive factors and their role in 
fetal allograft protection
Roth, Terri Lynn, Ph.D.
The Louisiana State University and Agricultural and Mechanical Col., 1991
UMI
300 N. ZeebRd.
Ann Arbor, MI 48106

CONCEPTUS-DERIVED IMMUNOSUPPRESSIVE 
FACTORS AND THEIR ROLE IN FETAL 
ALLOGRAFT PROTECTION
A Dissertation
Submitted to the Graduate Faculty
of the
Louisiana State University
and
Agricultural and Mechanical College
in partial fulfillment of the 
requirements for the degree of
Doctor of Philosophy
in
The Department of Animal Science
by
Terri Lynn Roth 
B.S., University of California Davis, 1986 
M.S., University of California Davis, 1988
August 1991
ACKNOWLEDGEMENTS
I would first like to thank ray major professor, Dr. Kenneth L. 
White, for initially convincing me to pursue iry Ph.D. degree at 
Louisiana State University, then for providing the opportunity for me 
to carry out the research in which I was most interested and finally, 
for his contributions to this research. I am also grateful to Dr. 
Donald L. Thorrpson, Jr. for kindly allowing me to use his horses. My 
sincere appreciation is extended to Dr. David W. Horohov, both for his 
helpful advice and for sharing with me his extensive knowledge of 
immunology. My gratitude is also extended to Dr. Kenneth L. White, 
Dr. David W. Horohov, Dr. Donald L. Thatpson, Jr., Dr. Lee L. 
Southern, Dr. William Hansel and Dr. Joseph C. Newton for their 
helpful suggestions in preparing this dissertation and for serving as 
members of iry committee.
I would like to thank my colleagues, Saeed Rahmanian, Don 
Colbom, Joe Capehart, Brett Barry and Mary Rabb for their assistance 
at the horse farm. Special thanks is extended to Dr. Bill Swanson for 
including me in his work at the local zoos and for offering his 
invaluable friendship. Finally, I would like to thank the L.S.U. 
Board of Regents for the generous fellowship that supported me during 
this doctoral program.
TABLE OF CONTENTS
PAGE
AOONCWLEDGEMENTS........................................ ii
LIST OF TABLES.......................................... vi
LIST OF FIGURES........................................ vii
LIST OF ABBREVIATIONS................................. viii
ABSTRACT................................................ ix
INTRODUCTION............................................ xi
CHAPTER I. Literature Review............................... 1
IMMUNE RESPONSES AND ALLOGRAFT REJECTION.................. 1
The History of Allografts............................ 1
Humoral Irrenune-mediated Graft Rejection................ 2
Cell-mediated Graft Rejection......................... 3
T Lymphocytes      „ ...........................3
T Lymphocyte Activation............................5
The IL-2 Receptor.................................5
Cytotoxic T Lymphocytes............................6
Additional Cell Types Affected by IL-2...............7
Suppressor Cells..................................8
In Vitro Assessment of Immune Cell Function............. 9
Mitogen-stimulated Proliferation.................... 9
Mixed Lymphocyte Reaction. ...................... 9
Cytolytic Cell Assays............................ 10
THE PUTATIVE IMMUNO-PROTECTIVE ROLE OF THE PLACENTA.........11
The Phenomenon of the Fetal Allograft................. 11
The Equine Placenta.................................12
Hybrid and Interspecific Pregnancies.................. 14
The Murine Model.................................15
The Sheep/Goat Model............................. 17
The Equine Model.................................19
Exotic Interspecies Pregnancies.................... 21
Embryo Manipulation.................................23
IMMUNOSUPPRESSION AND PREGNANCY......................... 26
Antibody Involvement................................ 26
iii
Suppressor Cells................................... 27
Macrophage Involvement in Immunosuppression............ 28
Suppressor Activity of Prostaglandins and Hormones.......28
Soluble Suppressor Factors...........................30
Murine......................................... 30
Human.......................................... 32
tftigulate....................................... 33
Rationale of Present Research........................ 35
CHAPTER II. Suppression of Sheep and Goat lyirphocyte
proliferation fcy sheep, goat and sheep x goat
hybrid trophoblast tissue cultures...............38
HSFTROEOSTION......................................... 38
MATERIALS AND METHODS..................................39
RESULTS..............................................42
DISCUSSION........................................... 45
CHAPTER III. Suppression of lyirphocyte proliferation
fcy a >30,000 MW factor in horse conceptus-
conditioned medium............................ 52
INTRODUCTION......................................... 52
MATERIALS AND METHODS....................   54
RESULTS..............................................58
DISCUSSION........................................... 66
CHAPTER IV. PGE2 - Independent immunosuppressive activity
of horse trophoblast tissue.....................72
INTRODUCTION......................................... 72
MATERIALS AND METHODS..................................73
RESULTS..............................................75
DISCUSSION........................................... 77
CHAPTER V. Horse conceptus-derived suppression of
T and B lymphocyte proliferation: interleukin-2
receptor involvement............................82
INTRODUCTION......................................... 82
MATERIALS AND METHODS..................................85
RESULTS.......... 96
iv
DISCUSSION.........   107
SUMMARY AND CONCLUSIONS.................................. 118
LITERATURE CITED........................................123
APPENDIX ...............................................148
VITA....................................................151
v
LIST OF TABLES
TABLE PAGE
1. Suppression of FWM-stimulated sheep and goat 
lymphocyte proliferation fcy caprine, hybrid and
ovine trophoblast tissue-conditioned medium................. 46
2. Effect of control medium and HCCM from Groups
I-III on mitogen-stimulated horse PBL proliferation...........59
3. Effect of treated HCCM on FWM-stimulated
horse PBL proliferation...................................61
4. PGE2 concentrations in horse trophoblast- 
conditioned medium (HTCM) and indomethacin-
treated HTCM (I-HTCM).................................... 78
5. The effect of HCCM I and HCCM II on FWM-
stimulated lynphocytes................................... 87
6. Effect of HCCM II supplementation to mitogen-
stimulated lynphocytes............   97
7. Effect of fractionated HCCM II and CM on CTLL-2
cells and murine splenocytes............................. 105
8. Fluorescence activated cell sorter analysis.................106
vi
LIST OF FIGURES
FIGURE PAGE
1. The effect of caprine, ovine and hybrid trophoblast 
tissue-conditioned medium on FWM-stimulated sheep
lyirphocyte proliferation.................................43
2. The effect of caprine, ovine and hybrid trophoblast 
tissue-conditioned medium on FWM-stimulated goat
lyirphocyte proliferation.................................44
3. Suppressive activity of treated vs non-treated
HCCM on FWM-stimulated PEL proliferation................... 62
4. Effect of >10,000 and <10,000 MW fractions of
HCCM and CM on FWM-stimulated PEL......................... 63
5. Effect of >30,000 and <30,000 MW fractions of
HCCM and CM on FWM-stimulated PBL......................... 64
6. Effect of HCCM on FWM-stimulated PBL of horses,
donkeys and goats.......................................65
7. Effect of indomethacin control medium, horse trophoblast- 
conditioned medium (HTCM) and indomethacin-treated HTCM
on FWM-stimulated horse PBL proliferation.................. 76
8. Serial dilutions of PHA tested in an equine
lyirphocyte proliferation assay............................89
9. Effect of HCCM I supplementation to FWM-stimulated 
lyirphocyte cultures at 0, 24 and 48 hours after the
start of culture........................................98
10. Response to PWM-stimulation following pre­
incubation of cells with HCCM II.......................... 99
11. Effect of PHA-stimulated equine PEL supernatant 
supplementation to HCCM II-treated, FWM-
stimulated lynphocytes..................................101
12. Effect of human recombinant IL-2 supplementation on 
proliferation of HCCM I-treated, PHA-stimulated equine PELs...102
13. Effect of rIL-2 supplementation to non-stimulated,
PHA-stimulated and PHA-stimulated + HCCM II-treated
cell cultures ........................................ 103
14. Two-dimensional scatter analysis with side
and forward light scatter parameters to examine
the effect of HCCM on cell blastogenesis................... 108
vii
LIST OF ABBREVIATIONS
CCM - caprine conditioned medium.
Con A - concanavilin A.
CM - control medium.
CTL - cytotoxic T lyirphocyte.
CTLL - cytotoxic T lyirphocyte line.
CTLL-2 - IL-2 dependent cytotoxic T lyirphocyte line.
FACS - fluorescence activated cell sorter.
FF - fresh frozen.
FITC - fluorescein isothiocyanate.
FSH - follicle stimulating hormone.
FT - frozen-thawed 8X to -80° C.
HCCM - horse conceptus conditioned medium.
HCCM-1 - horse conceptus conditioned medium with fetal calf serum. 
HCCM-II - horse conceptus conditioned medium without fetal calf serum. 
HCCM-SF - horse conceptus conditioned medium suppressor factor.
HCM - sheep x goat hybrid conditioned medium.
HMWGP - high-molecular-weight glycoprotein.
HBSS - Hank's basic salt solution.
HT - heat-treated 90°C for 30 min.
HTCM - horse trophoblast conditioned medium.
ICM - inner cell mass.
I-CM - indomethacin control medium.
I-HTCM - indomethacin- treated horse trophoblast conditioned medium. 
IL-1 - interleukin-1.
IL-2 - interleukin-2.
IL-2R - interleukin-2 receptor.
rIL-2 - human recombinant interleukin-2.
LPS - lipopolysaccharide.
MHC - major histoccmpatability.
MLR - mixed lyirphocyte reaction.
1CF - nitrocellulose filtered.
NK - natural killer.
OCM - ovine conditioned medium.
PBL - peripheral blood lynphocytes.
PBMC - peripheral blood mononuclear cells.
PBMCS - peripheral blood mononuclear cell supernatant.
PBS - phosphate buffered saline.
PBS-GS - phosphate buffered saline + 10% goat serum.
PHA - phytohemagglutinin.
PGE2 - prostaglandin E2 
PP14 - placental protein 14.
FWM - pokeweed mitogen.
RIA - radioimmunoassay.
PZP - pregnancy zone protein.
RPMI+ - RPMI-1640 medium + 1% penicillin/streptonycin + 10% calf serum 
SIF - suppressor inducer factor.
TCR - T cell receptor.
ULP - uterine luminal protein.
UIM-P - uterine milk protein.
viii
ABSTRACT
The role of conceptus-derived immunosuppressive factors in 
protecting the fetal allograft was investigated by first examining the 
immunosuppressive activity derived from ovine, caprine and hybrid 
conceptus trophoblast tissue. Medium conditioned by 20 day-old 
conceptus trophoblast tissue from each species suppressed sheep and 
goat lymphocyte proliferation (Pc.01). There were no differences 
(P>.05) between the immunosuppressive effects of the three media on 
either sheep or goat lynphocytes. In subsequent studies, horse 
conceptus-conditioned medium (HCCM) derived from embryos at days 9, 15 
and 26 of gestation, suppressed mitogen-stimulated horse lynphocytes 
(Pc.001). HCCM maintained its suppressive activity following heating 
and repeated freeze-thawing. Using microconcentrator centrifugation, 
it was determined that the suppressor factor(s) was >100,000 MW. HCCM 
was tested in donkey and goat lymphocyte cultures and proved capable 
of suppressing proliferation of xenogeneic lynphocytes (Pc.01). 
However, the suppressive capacity of HCCM in caprine lymphocyte 
cultures was less (P<.05) than that in equine cultures. Trophoblast 
tissue of 21 day-old horse conceptuses was cultured in the presence 
and absence of indomethacin. Both immunosuppressive activity and the 
concentration of prostaglandin E2 (PGE2) in the medium of each culture 
were measured. While PGE2 production was greatly reduced in cultures 
containing indomethacin, trophoblast-derived immunosuppressive 
activity was not affected (P>.05). The final stud/ involved partial 
characterization of the HCCM suppressor factor's (HCCM-SF) mechanism 
of action. By testing HCCM-SF in cultures stimulated with mitogens
ix
that selectively activate B and/or T lynphocytes, and ky sorting HCCM- 
SF-treated and non-treated cells labeled with fluorescent antibodies, 
it was determined that HCCM-SF acts on T lynphocytes. The temporal 
effect of HCCM-SF was also investigated and, compared to lynphocytes 
treated at time 0, proliferation was greater (Pc.01) in cultures 
treated with HCCM-SF 24 or 48 hours after the start of stimulation. 
Furthermore, the removal of HCCM-SF from lymphocyte cultures resulted 
in complete recovery of cell responsiveness. The addition of 
recombinant human IL-2 to the lymphocyte cultures did not overcome the 
suppressive effect of HCCM-SF (Pc.01), yet HCCM-SF had no effect on 
cells already expressing the high affinity IL-2 receptor (P>.05). 
HCCM-SF may be one factor responsible for inhibiting cell-mediated 
fetal allograft rejection during pregnancy.
x
INTRODUCTION
The mammalian placenta mediates numerous supportive functions 
related to the fetus that are necessary for maintaining a successful 
pregnancy. In acting as the organ of fetal respiration, nutrition, and 
excretion, the placenta facilitates metabolic exchanges between fetal 
and maternal blood while simultaneously impeding transplacental 
movement of many other substances. The placenta also plays an 
important role as an endocrine organ during gestation, but perhaps its 
most fascinating characteristic is the ability to maintain the fetus 
as an allograft in the mother.
Scientists have struggled for years to understand how nature 
circumvents the allograft reaction to allow for fetal survival. The 
motives for studying this phenomenon have been primarily two-fold. 
First, it is believed that some cases of infertility and recurrent 
abortion result from aberrant immunological conditions, but causal, 
atypical immunological events can only be identified and appropriately 
treated if the "normal" fetal-maternal relationship of successful 
pregnancies is understood. Second, information gained from the 
elucidation of the mechanisms underlying fetal allograft tolerance 
might prove valuable for those struggling to improve the proficiency 
of organ transplantation. While both motives still exist today, there 
is now a third and perhaps more critical incentive for solving the 
mysteries surrounding maternal acceptance of foreign fetal tissue. 
This third motive pertains to potential strategies for assisting 
reproduction of endangered species.
While the human population is expanding at an accelerated rate,
xi
species diversity on this planet is diminishing at a similarly 
alarming rate. In order to both protect and enhance proliferation of 
endangered species, it is imperative that some action be taken 
immediately. With the technological advances of the past decade, 
interspecific embryo transfer from endangered to non-endangered 
species has become an attractive strategy, unfortunately, the use of 
this procedure has met with only limited success. The etiology of 
failed interspecies pregnancies frequently indicates imnunological 
rejection. Therefore, it is anticipated that by achieving a 
comprehensive understanding of the fetal-maternal imnunological 
relationship, it will be possible to either choose more appropriate 
xenogeneic surrogate females or to modulate the in utero immune 
response of the surrogates such that the interspecific pregnancy is 
maintained. Perhaps then, the success of interspecific embryo transfer 
will attain the efficiency required to facilitate the propagation of 
sane imperiled species.
In this dissertation, one immunological aspect of the fetal- 
maternal relationship is examined. In order for the reader to gain 
insight into the philosophy of this work, the literature review in 
Chapter I encompasses three main topics. The first section describes 
components of the immune response that contribute to allograft 
rejection and that may play a role in the acceptance or rejection of 
the fetal allograft. The second section focuses on the large, 
convincing bod/ of evidence for the importance of the placenta in both 
protecting the fetal allograft and maintaining pregnancy. The final 
section of the literature review deals specifically with the concept
xii
of immunosuppression at the fetal-maternal interface, which is the 
focus of this research. Chapters II-V consist of the four manuscripts 
derived from this dissertation.
CHAPTER I .
LITERATURE REVIEW 
IMMUNE RESPONSES AND ALLOGRAFT REJECTION 
The History of Allografts
An allograft is a tissue that has been transplanted from one 
member of a species to another genetically distinct member of that 
species. The first allograft attempt was reported in 1503 by a 
surgeon who grafted skin from a slave for the reconstruction of the 
master's nose (from Auchincloss and Sachs, 1989). Skin grafting 
became common practice during the late 1800s, but it was mainly a 
technique used to promote the healing of a wound, and whether or not 
the graft "took", was of no great concern. A tremendous break-through 
for those studying graft acceptance and rejection in the early 1900's 
came from the observations of Sir Peter Medawar. Medawar critically 
evaluated some peculiar results of a clinical skin graft attempt and 
subsequently carried out a series of grafting experiments in rabbits 
(Medawar, 1944). Shortly thereafter, Medawar concluded that the 
rejection of allografts was a form of actively acquired immune 
reactions (Medawar, 1945). Little (1914, 1941) also made an
exceptional contribution towards our understanding of the success or 
failure of transplantation by describing the “laws of 
transplantation". These laws dealt with the genetic components 
contributing to graft rejection. In his interpretation of the 
complicated laws, Little proposed that there were multiple loci 
codominantely expressing their products, and if any such product was 
generated by the donor and not the recipient, the graft would be
1
2rejected (Little, 1914). Little's hypothesis (now considered a 
fundamental law) was largely responsible for stimulating subsequent 
investigations that led to the identification and characterization of 
the major histocompatibility complex (MHC) loci and associated 
antigens.
Today, we know that the extraordinarily polymorphic MHC antigens 
(Bell et al., 1985) can be divided into two general types called class 
I and class II MHC antigens. The class I antigens are found on 
virtually all nucleated cells of the body (Harris and Gill, 1986). In 
contrast, class II antigens are selectively present on several immune 
cells, such as macrophages, dendritic cells, B lymphocytes and human T 
lymphocytes (Daar et al., 1984). Initially, class I antigens were 
identified by antibodies. In contrast, class II antigens were 
identified by their ability to provoke allogeneic lymphocyte responses 
(Bach et al., 1972). Such responses are not unlike those that occur 
during allograft rejection.
Humoral Immune-mediated Graft Rejection.
Because B lymphocytes are responsible for the generation of 
antibodies, their primary role in graft rejection is mediated through 
a humoral immune response. There is sane evidence that pre-existing 
antibodies can cause antibody-mediated (hyperacute) graft rejection of 
vascularized organs (Williams et al., 1968). Such rejection is 
characterized by antibody binding to vascular endothelium which leads 
to severe thrombosis (Winn, 1986). Chronic antibody-mediated 
rejection has been implied in a few failed cases of transplantation 
where only a sparse cellular infiltrate was observed (Jeannet, 1970). 
However, a well defined mechanism for chronic humoral immune-mediated
3graft rejection has not been identified. Furthermore, skin grafts are 
resistant to hyperacute antibody-mediated rejection (Winn et al., 
1973). Instead, cell-mediated imnunological processes are responsible 
for skin graft rejections which occur one or more weeks following 
transplantation. Because the placental-uterine association is 
analogous to a skin graft-donor relationship, it is the cell-mediated 
response, or lack thereof, during pregnancy that receives the most 
attention when survival of the fetal allograft is studied.
Cell-mediated Graft Rejection.
Skin graft rejection is a highly specific and complex process 
involving both B and T lynphocytes, macrophages and natural killer 
(NK) cells (Hayxy et al., 1984; Tilney et al., 1984). Experiments in 
which syngeneic and allogeneic skin grafts were placed adjacent to 
each other resulted in an inflammatory rejection response to the 
allogeneic graft, yet the response abruptly ended at the interface of 
the syngeneic graft (Auchincloss and Sachs, 1989). Furthermore, when 
mosaic grafts of chimeric (tetraparental) mice were transferred to one 
of the parents, only allogeneic cells were destroyed while 
interspersed syngeneic cells were left unharmed (Mintz and Silvers, 
1970; Rosenberg and Singer, 1988). The specificity of graft rejection 
is a reflection of the T cell receptor's (TCR) specificity for foreign 
cells.
T Lymphocytes
The importance of T lynphocytes in cell-mediated graft rejection 
has been demonstrated in vitro fcy their role in non-antibody mediated 
cytotoxicity, and in vivo fcy their significant predominance in the 
cellular filtrate of rejected transplants. Further confirmation has
4been obtained experimentally by the demonstration that T cell 
deficient rats indefinitely accept cardiac allografts (Iga et al., 
1985) and a thymic mice accept not only allogeneic grafts, but also 
xenogeneic grafts (Manning et al., 1973). In addition, when such mice 
are re-populated with purified T cells, the animals regain the 
capacity to reject grafts (Sprent et al., 1986; Rosenberg et al., 
1987). While it is widely accepted that T cells are largely 
responsible for graft rejection, there is still controversy regarding 
the specific T cell subsets or mechanisms involved (Steinmuller, 1985; 
Mason and Morris, 1986).
T cell development is accompanied by changes in cell surface 
structures and these surface antigens serve as phenotypic markers for 
cells with different physiological functions. The T cell population 
is divided into two general sub-populations on the basis of the 
expression of the specific cell surface antigens, CD4 and CD8 
(Reinherz and Schlossman, 1980; Raff, 1971; Cantor and Bqyse, 1975). 
Expression of the CD4 and CD8 antigens is associated with the function 
of the cells. Thus, CD4+ cells are known as T helper cells and CD8+ 
cells are T cytotoxic/suppressor cells. CD4 and CD8 antigens are also 
involved in and predict the TCR's mechanism of antigen recognition. 
The TCR of CD4+ cells recognize antigen in the context of class II MHC 
while the TCR of CD8+ cells recognize antigen in the context of class 
I MHC (Swain, 1983). Reconstitution of T cell-deficient mice with 
either CD4+ or CD8+ T cell populations re-establishes the animal's 
ability to reject grafts (Wheelahan, 1987; Auchincloss et al., 1988). 
It has been reported that rejection of grafts expressing only class I 
antigenic differences is dependent on CD8+ lynphocytes while CD4+ cell
participation is required for rejection of grafts expressing only 
class II differences (Rosenberg et al., 1986,1987). These 
observations are compatible with the theory that the T cell, and more 
specifically TCR recognition of foreign MHC, is responsible for 
rejecting grafts.
T. .Lymphocyte Activation
In a primary immune response, T cell activation occurs when the 
antigen specific TCR is stimulated by a foreign antigen in the context 
of an appropriate MHC antigen. Following activation, the cell 
undergoes dramatic changes including an increase in cell volume (blast 
transformation), an increase in ENA synthesis and the generation of 
specific cell products. These events result in clonal expansion of 
specific T cells. Additionally, the cells differentiate and acquire 
specific functions associated with T helper or T cytotoxic/suppressor 
cells. T helper cells (CD4+) produce interleukin-2 (IL-2) which 
serves as the necessary secondary signal (following antigen 
stimulation) for inducing proliferation of T cells (Bonnard et al., 
1979; Smith, 1980) as well as for generating OIL activity (Farrar et 
al., 1981). The ability of T cells to respond to IL-2 depends on 
activation of the cells to express the high affinity IL-2 receptor 
(IL-2R) (Bonnard et al., 1979; Smith, 1980).
The IL-2 Receptor
The IL-2R has been identified and described as a dimer 
consisting of a p55 alpha chain with low affinity for IL-2 and a p75 
beta chain with slightly greater IL-2 affinity (Greene et al., 1986; 
Tsudo et al., 1986; Teshigawara et al., 1987; Smith, 1988a). With 
mitogenic or allogeneic stimulation, the two chains are expressed
together on the cell surface to form the high affinity IL-2R complex 
which, when bound to IL-2, is largely responsible for signaling cell 
proliferation (Sharon et al., 1986; Smith, 1988b). The significance 
of this high-affinity IL-2R has been demonstrated fcy experiments in 
which an antibody to the IL-2R (anti-Tac) blocks IL-2 binding (Robb et 
al., 1981; Leonard et al., 1982; Sharon et al., 1986), therefcy 
inhibiting cell proliferation (Robb et al., 1981). In addition, 
antibody blocking of the IL-2/IL-2R interaction has effectively 
prevented allograft rejection (Kirkman et al., 1985). While T helper 
cells serve as the source of IL-2, IL-2R are expressed on T helper, T 
cytotoxic/suppressor and even activated B cells (Waldmann et al., 
1984). Thus, IL-2 can have a significant inpact on several cell types 
involved in cell-mediated immune responses.
Cvtotoxic T Lymphocytes
Cytotoxic T cell differentiation and activation are dependent on 
IL-2 production fcy T helper cells (Nabholz and MacDonald, 1983). This 
effect of IL-2 is largely responsible for the synergism of the two 
cell types that has been observed both in vivo (Cantor and Asofsky, 
1971) and in vitro (Wagner, 1973). While IL-2 has been promoted as 
the lymphokine responsible for the secondary stimulus required for 
complete CIL activation, it has recently been reported that IL-4 may 
be equally effective in its ability to serve as a helper factor for 
CIL generation (Widmer and Grabstein, 1987). Nevertheless, IL-2 
induction of CIL proliferation may be an important event associated 
with graft rejection. Convincing evidence exists for CIL involvement 
in the rejection process. For example, using flow cytometric 
analysis, a shift in the ratio of CD4+ to CD8+ cells (from 1.6 on day
73 to .7 on day 5), was found to be associated with the period of most 
intense immunological graft destruction (Tilney et al., 1986). In 
addition, specific, MHC-restricted allograft rejection in vivo by 
cloned CTLs has been reported (Snider et al., 1986).
Mditional Cell Types Affected b/ IL-2
In addition to its effects on T cells, IL-2 can promote the 
activation of other cells associated with, or involved in, the 
rejection of allografts. Activated B cells express the high affinity 
IL-2R (Waldman et al., 1984) and IL-2 promotes both proliferation and 
differentiation of B cells. Furthermore, IL-2 regulates B cell 
production of antibodies (Jelinek and Lipsky, 1987). At high 
concentrations, IL-2 has been shown to enhance cytotoxic activity in 
macrophages (Malkovsky et al., 1987). Similarly, NK cells respond to 
IL-2 with augmented cytotoxic activity, IL-2 receptor expression, 
proliferation and increased interferon gamma production (Trinchieri et 
al., 1984; Brooks and Henney, 1985; Malkovsky et al., 1987). 
Together, these findings indicate multiple regulatory effects of IL-2 
on immune function.
A role for NK cells and/or macrophages in graft rejection has 
not been elucidated. While they do exist as somewhat minor 
populations in cellular infiltrate of rejected grafts (Haryry et al., 
1984; Tilney et al., 1984), their significance is not understood. 
Macrophages participate in cell mediated immunity by interacting 
specifically with lynphocytes to promote antigen-specific responses, 
by their ability to phagocytize cells specifically labeled fcy 
antibodies and fcy direct cytotoxicity (Anderson and Hill, 1988).
8Similarly, NK and killer cells are capable of cytolytic activity 
mediated fcy antibodies.
Suppressor Cells
While atterrpts to maintain allografts have focused mainly on 
procedures that might interfere with or reduce effector cell function, 
an alternate method might be through the induction of imnune 
suppressor cells. Results of various methods used to identify 
suppressor cells have implicated both T and B lynphocytes (Katz et 
al., 1974; Zubler et al., 1980) as well as macrophages (Baird and 
Kaplan, 1977; Oehler et al., 1977) as mediators of suppression. 
However, overwhelming evidence .indicates that T cells, specifically 
CD8+ cells, are responsible for most suppressor cell activity. When 
CD8+ cells were added to mixtures of B cells and T helper cells, 
antibody production was substantially reduced (Hodes, 1989). It has 
been suggested that suppressor cells serve more as homeostatic 
regulators of immune responses than mediators of complete 
unresponsiveness (Eardley and Gershon, 1975; Eardley et al., 1978). 
Such regulatory mechanisms could be associated with allograft 
acceptance and/or rejection. Antigen non-specific T suppressor cells 
have been identified during graft-versus-host disease following bone 
marrow transplantation (Pickel and Hoffmann, 1977; Shearer and 
Folisson, 1980), indicating a role for these cells in failed grafts. 
There is also evidence for suppressor cell involvement in the fetal 
allograft phenomenon and these studies will be discussed in the 
following sections. Unfortunately, even with the tremendous quantity 
of information pertaining to suppressor cells, the basic mechanism 
underlying the functions of such cells remains largely unresolved.
9In Vitro Assessment of Immune Cell Function
Mitogen-stimulated Proliferation
While lymphocyte activation generally requires stimulation by 
antigen in the context of MHC, there are reagents available that 
obviate the need for specific antigen stimulation. These reagents 
include lectins or mitogens which can polyclonally activate cells by 
binding non-specific carbohydrate groups on the lynphocyte surface 
(Sharon, 1983). Plr/tohemagglutinin (PHA) (Nowell, 1960), concanavilin 
A (Con A) and pokeweed mitogen (PWM) were among the first lectins 
identified. The ability of Con A and PHA to selectively stimulate T 
cells is likely due to their binding of carbohydrate groups expressed 
on T cell receptors (Sharon, 1983). In fact, results from recent 
studies indicate the lectins bind directly to components of the T cell 
receptor (Weiss et al., 1987). In contrast to these T cell mitogens, 
EWM primarily stimulates B cells while also affecting T cells. 
Lipopolysaccharide (LPS) endotoxin also serves effectively as a 
mitogen, but it non-specifically stimulates B cells to proliferate, 
differentiate and produce antibodies (Kincade and Girrtole, 1989). 
These potent lymphocyte stimulators have facilitated the study of non­
specific immune cell responses in vitro.
Mixed Lvmohocvte Reaction
Another in vitro assay that has been extensively used to 
investigate cell mediated immune responses is the mixed-lynphocyte 
reaction (MLR). This assay exploits the fact that T cells recognize 
non-self MHC antigens as foreign, and the stimulation ty this 
"foreign" antigen causes the cells to undergo transformation and 
proliferation. Because of this blast response by lymphocytes to
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allogeneic stimuli, the assay has been referred to as the in vitro 
correlate of allograft rejection (Andersson and Hayry, 1974). Cell 
proliferation in this assay can be assessed ty measuring cell uptake 
of a radiolabeled precursor supplemented to the culture medium. Due 
to the nature of the cellular response in this assay, it has been used 
for tissue typing (Roit, 1987) and is still frequently used to assess 
the relatedness of two individuals. In addition, MLRs have been used 
to identify suppressor activity of immune cells obtained from the 
placenta (Uren and Beyle, 1990) and to assess soluble suppressor 
factors found in conceptus culture medium (Murray et al., 1987). 
Cvtolvtic Cell Assays
The ability to measure cytolytic activity of cytotoxic T cells 
ty using target cells that have incorporated 5^ Cr, released and 
measurable upon lysis of that cell, provides another mechanism that 
can be used when examining antigen-specific, cell-mediated immune 
responses in vitro. Such an assay is particularly relevant in studies 
of allograft rejection because of the involvement of CTL in this 
response. In contrast to the cytolytic assay, a CTL proliferation 
assay is used to quantify IL-2. Due to the potent effect of IL-2 on 
CTL proliferation, it was possible to establish a murine cytolytic T 
lynphocyte line (CELL) for measuring IL-2. These CTLL cells 
constitutively express the high affinity IL-2R and proliferate only in 
response to IL-2. In the absence of IL-2, the cells cease to 
proliferate and die within 12-18 hours. Even more important, the 
degree of CTLL proliferation is dependent on the concentration of IL-
2. Therefore, quantitative measurements of IL-2 activity in various 
samples can be determined with these cells (Gillis et al., 1978).
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THE PUTATIVE IMMUNO-PROTECTIVE ROLE OF THE PLACENTA 
The Phenomenon of the Fetal Allograft
Mammalian pregnancies are generally characterized by the 
successful development of allogeneic conceptuses intimately associated 
with maternal uterine tissue. Maternal acceptance of the fetal 
allograft represents a unique case of immunological tolerance that is 
consistently reproducible. For decades scientists have been 
challenged to explain how the feto-placental unit survives to term 
while artifactual allografts repeatedly fail.
In 1953, Medawar offered potential solutions to the rrystery. 
Based on his solutions, Billingham (1964) and Simoons (1969) 
formulated hypotheses pertaining to the mechanisms possibly involved. 
The proposed mechanisms included: 1) The uterus is an immunologically 
privileged site 2) The conceptus is antigenically immature 3) The 
placenta provides a barrier to cellular and humoral maternal-fetal 
interactions 4) The maternal immune system is suppressed and 5) The 
immune response of the mother is qualitatively different during 
pregnancy such that it promotes fetal survival. The first option has 
been eliminated (Beer and Billingham, 1976) since it has been shown 
that the uterus possesses an immune system capable of tissue-graft 
rejection (Reimers and Dzuik, 1974). There is substantial evidence 
against the second option as the conceptus expresses several classes 
of alloantigens and isoantigens on its cell surfaces (Wegmann et al., 
1979; Chatterjee-Hasrouni and LaLa, 1982; Lala et al., 1983; Johnson, 
1984; Crunp et al., 1987; Donaldson et al., 1990). Furthermore, the 
presence of anti-fetal antibodies frequently identified in maternal 
circulation, refute both options 2 and 4 (Terasaki et al., 1970;
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Newman and Hines, 1980; Smith et al., 1982; Antczak et al., 1984). 
Finally, there is a complete lack of evidence supporting option five. 
The potential role of the placenta as the primary barrier to 
immunological rejection (option 3) has increasingly received greater 
attention with the accumulation of evidence against the other 
hypotheses.
The Equine Placenta
The term "placental barrier" has long been used to describe the 
tissue layers separating fetal and maternal blood supplies. The role 
of the placenta as a "barrier" differs both structurally and 
physiologically between species. Equine placentae, in particular, are 
characterized ty specialized structures with functions unique to the 
species. Because the research described in this dissertation focuses 
largely on the horse conceptus, a brief description of implantation 
and placental formation in this species is warranted.
Oviductal transport in the mare appears to be selective for 
fertilized embryos, and oocytes are only rarely found in the uterus. 
Horse embryos enter the uterus as early blastocysts on day 5 or 6 
after ovulation (Hamilton and Day , 1945; Oguri and Tsutsumi, 1972). 
Normally developing embryos hatch frcxn their zonae pelucidae on day 8 
or 9, but remain encapsulated ty another non-cellular, translucent 
membrane referred to as the embryonic capsule (Flood and Betteridge, 
1982). Trans-uterine migration of the embryonic vesicle ceases hy day 
15 when fixation occurs in one of the uterine horns (Ginther, 1986). 
Vesicle expansion and fetal development proceed, but actual 
implantation does not begin until day 36 of gestation (Allen et al., 
1973).
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Placentation in equids is uniquely characterized ty the 
formation of structures known as endometrial cups. These cups 
originate from specialized trophoblast cells, chorionic girdle cells, 
which invade the maternal endometrium between days 36 and 38 after 
ovulation (Allen and Moor, 1972; Allen et al., 1973). Within 24 
hours, these cells migrate into the uterine stroma, increase in size 
and begin secreting equine chorionic gonadotrophin (eCG). Leukocytes, 
primarily lymphocytes, immediately accumulate around the developing 
endometrial cups and their numbers increase as gestation progresses 
(Allen, 1979). While these cells appear to "wall off" each cup from 
the uterine stroma, it is not until day 70 or 80 that the lymphocytes 
invade the cups. This invasion of immune cells leads to the 
destruction of the endometrial cups and ty day 120, the tissue sloughs 
into the uterine lumen.
The nature of the intense lymphocyte accumulation surrounding 
the endometrial cups remains unclear. A similar response is not 
observed around the non-invasive trophoblast of the allantochorion 
(Allen, 1975) indicating that cup cells may express antigens not 
present on other trophoblast cells. The fact that antibodies to fetal 
major histocompatibility complex (MHC) antigens are present in 90% of 
mares carrying MHC - incompat ible fetuses (Bright et al., 1978; DeWeck 
et al., 1978), and that these antibodies are detected 2 to 4 weeks 
after cup formation (Antczak et al., 1984) would indicate that 
paternal MHC-antigens are present on endometrial cup cells. Indeed, 
Crump et al. (1987), provided conclusive evidence for the expression 
of paternal MHC antigens on the invasive chorionic girdle cells at day 
33 of gestation. In addition, Donaldson et al. (1990), found that
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class I MHC antigen expression was largely restricted to the early 
stages of trophoblast invasion. They reported a reduction in MHC 
antigens on mature cup cells and suggested that developnentally 
regulated MHC expression may serve as one defense against alloirrmune 
rejection mechanisms. Surely, this phenomenon supports the suggestion 
that the placenta plays a role as an iranuno-protective barrier for the 
fetal allograft. Conversely, a vigorous leukocyte reaction against 
MHC-compatible endometrial cups has been observed (Allen et al., 1983 ; 
Antczak and Allen, 1984) indicating that MHC antigens are not 
primarily responsible for the immune response against endometrial 
cups.
Hybrid and Interspecific Pregnancies
The study of both successful and failed hybrid and interspecific 
pregnancies, has led to a greater appreciation for the placenta's role 
in preventing immunological rejection of the fetus. The three most 
thoroughly studied models of hybridism are the murine model of Mjs 
musculus and M. caroli, the equine model involving primarily the 
domestic horse and donkey and a model involving two genera, the 
domestic sheep (Ovis aries) and goat (Capra hircus). While exhibiting 
sane similarities, each model is unique with respect to success rates, 
complications and characteristic abnormalities relative to 
intraspecific pregnancies. Immunological interference appears to be 
involved in, if not responsible for, anomalies associated with 
interspecific pregnancies, tut how this iranune interference is 
manifested differs with species.
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The Marine Model
The murine model of interspecific pregnancy has been intensively 
studied (Rossant et al., 1982; 1983a and Crcy, 1985). While M. caroli 
and M. musculus have the same diploid chromosome number they do not 
readily hybridize. Both fertilization and postinplantation survival 
rates are extremely low (West et al., 1977), but such failure likely 
results from retarded development of hybrids relative to either 
parental species (Frels et al., 1980). Such retarded development 
indicates genomic incorrpatibility and not immunological interference 
as the primary cause of pregnancy failure, and will therefore not be 
discussed further. Results from interspecific embryo transfer between 
the two murine species have revealed a more puzzling situation. 
Survival to term of M. caroli embryos transferred to M. musculus 
recipients was very low (1/69) while M. musculus embryos transferred 
to the same recipients developed normally (Frels et al., 1980). 
Furthermore, Cray et al. (1982) noted that after 9.5 days of 
apparently normal development, the M. caroli placental trophoblast 
layer became infiltrated with lymphocytes and hemorrhage occurred, 
while M. musculus embryos in the same uterus were unaffected. 
Cytotoxic T lymphocytes that lysed M. caroli target cells were 
identified at the resorption sites indicating irrmunological 
involvement in the demise of M. caroli embryos. Additional evidence 
for immunological involvement in fetal survival was reported by Clark 
et al. (1983) who found that while decidual cells with 
immunosuppressive capabilities are present during intraspecies 
pregnancy in one uterine horn, they are not detectable in decidua of 
xenogeneic (M. caroli) conceptuses that have implanted in the opposite
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uterine horn. It was hypothesized that M. caroli trophoblast failed 
to recruit or stimulate these suppressor cells.
The fact that the conceptus represents a unique type of 
allograft is supported ty the results of experiments involving the 
transfer of M. caroli embryos to M. musculus recipients with 
genetically or experimentally altered immune function. M. caroli 
survival in M. musculus females was not improved when recipients were 
treated with Cyclosporin A which is capable of inhibiting T-lymphocyte 
mediated rejection of transplants (Cray et al., 1985b). In the same 
study, M. musculus recipients that were either athymic (T cell 
deficient) or natural killer (NK) cell deficient failed to support M. 
caroli embryo development, yet the athymic recipients did accept M. 
caroli skin grafts. While these data may refute the hypothesis of 
immune system involvement with interspecific pregnancy failure in this 
model, the results are complicated ty the confounding effect of immune 
system alterations on pregnancy in general. Difficulties were 
reported maintaining pregnancies in athymic M. musculus females 
following the transfer of M. musculus embryos (Cray et al., 1985b). 
The failure of putatively immuno-incompetent M. musculus mice to 
support M. caroli embryos has been explained as a result of M. 
musculus hypersensitivity (pre-existing immunity) to M. caroli 
antigens (Clark et al., 1986). However, the basis for this pre­
existing sensitivity was not given.
Why interspecific pregnancies proceed successfully when M. 
musculus embryos are transferred to M. caroli recipients, yet fail 
consistently when the species of embryo and recipient are reversed, 
remains unclear. It has been reported that fewer suppressor cells are
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present in the decidua of M. caroli conceptuses than M. musculus 
conceptuses during intraspecific pregnancies (Clark et al., 1986). In 
addition, M. caroli placental cells exhibited less inherent ability to 
inhibit cytotoxic effector cell killing when compared to M. musculus 
placental cells. In view of this data, it has been suggested that, 
compared to M. musculus, M. caroli conceptuses have a weakened defense 
against maternal immune attack even in the M. caroli uterus (Anderson, 
1988). Even with the substantial quantity of information obtained, 
the exact mechanism responsible for the failure or success of M. 
musculus/M. caroli interspecific pregnancies has not been defined. 
However, it is widely believed that a maternal immune response and a 
failure of conceptus-derived local immunoregulation are primary 
contributors to the death of xenogeneic embryos.
The Sheep/Goat Model
Scientists have been puzzled for years over the failure of 
domestic sheep x goat hybrid pregnancies when the two species are 
frequently observed mating. Interspecific fertilization failure was 
initially suggested as an explanation for failure of hybrid 
pregnancies, tut this theory was refuted long ago (Warwick and Berry, 
1949; Bratanov and Dikov, 1962). Despite the fact that fertilization 
between sheep and goats does occur, hybrid embryos invariably die 
during the first 2-3 months of gestation (Warwick and Berry, 1949; 
Alexander et al., 1967). Death does not appear to be caused ty 
cytological anomalies associated with altered chromosome numbers 
(Buttle and Hancock, 1966). In addition, Hancock and Jacobs (1966) 
found no evidence of developmental abnormalities that might explain 
early death. It was suggested that because the caprine placenta
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differs from that of the ovine in that it is not a source of 
progesterone (Amoroso and Perry, 1975), the hybrid placenta may prove 
to be deficient in progesterone production. Such a hormone deficiency 
could lead to endocrine-associated pregnancy failure. However, 
McGovern (1976) was unsuccessful in extending the survival of the 
hybrid fetus ty administering exogenous progesterone to recipient 
does.
While all of the factors mentioned above may contribute to sheep 
x goat hybrid pregnancy loss, there is an overwhelming body of 
evidence which suggests that pregnancy failure is due to irrmunological 
incompatibility between maternal and fetal tissues. Numerous reports 
of abnormal histological and ultrastructural characteristics of 
placentae in hybrid pregnancies (Alexander et al., 1967; Hancock et 
al., 1968; McGovern 1973a; Dent et al., 1971a,b) support the idea that 
the maternal inmune reaction is directed against the hybrid placenta 
and not the fetus itself. Hybrid placentae development was 
extensively studied by Hancock et al., 1968. They reported that in 
sane pregnancies the fetal membranes failed to establish normal 
contact with the uterus and caruncular development was incomplete. A 
similar deficiency in trophoblast invasion has been reported following 
the transfer of sheep embryos to goat recipients (Hancock et al., 
1968). In either case, fetal death results. By contrast, in other 
hybrid pregnancies and when goat embryos developed in sheep 
recipients, cotyledonary development was prominent and invasion of 
uterine tissue by trophoblast was extensive. In such cases, necrosis 
of both fetal and maternal tissues occurred, acconpanied by maternal 
immune cell infiltration. Large aggregation of platelets and lobular
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swelling of the endothelium were identified in maternal capillaries 
beneath the uterine epithelium. Similar observations are
characteristic of viscera undergoing rejection and of blood vessels 
damaged by antigen-antibody complexes. The fact that hybrid pregnancy 
failure occurs earlier during gestation in second-time recipients or 
in recipients immunized with xenogeneic paternal leukocytes, supports 
the theory that an immunological reaction is the primary factor 
resposible for hybrid fetal death (McGovern, 1973).
TJhg-Jming_Matel
Equidae are unique in that hybrid and interspecific pregnancies 
are possible across a variety of species with wide chromosomal 
differences (Short et al., 1974; Benirshke and Ryder, 1985). 
Nevertheless, relative to intraspecific pregnancies, there are 
significant alterations in endometrial cup formation and survival, eCG 
secretion and leukocyte accumulation in interspecific or hybrid 
pregnancies. Results from numerous studies indicate that the immune 
system is primarily responsible for aberrant cup formation.
The transfer of horse embryos to donkey recipients appears to be 
more successful than the transfer of donkey embryos to horses. 
Compared to intraspecific donkey pregnancies, horse-in-donkey 
pregnancies result in the formation of larger endometrial cups 
surrounded by excessive numbers of accumulated leukocytes (Allen et 
al., 1985). Despite the increased number of leukocytes, the cups 
remain intact past day 100 of gestation and pregnancy proceeds 
successfully. In contrast, donkey embryos develop normally in horse 
recipients up to day 70 despite a complete lack of endometrial cup 
formation. Thereafter, they succumb to a vigorous cell-mediated
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maternal immune response directed against the allantochorion. Similar 
to observations of horse-in-donkey pregnancies, are reports of hinny 
pregnancies (female donkey bred to male horse) in which there are an 
excessive number of leukocytes surrounding the highly invasive 
endometrial cup tissue yet the cups maintain a normal lifespan of 80 
to 100 days (Allen, 1982b). In contrast, mule pregnancies (female 
horse bred to male donkey) are characterized ty intensive lymphocyte 
infiltration deep into the endometrial cups Which results in complete 
loss of cup tissue ty day 60 of gestation (Allen et al., 1982b). 
Surprisingly, mule pregnancies are successful despite the early loss 
of endometrial cup tissue.
Various therapies have been used in hopes of promoting the 
successful maintenance of donkey-in-horse pregnancies. Daily 
administration of a synthetic progestin to mares with donkey fetuses 
failed to prevent pregnancy failure (Allen 1982b; Allen et al., 1985). 
Injections of partially purified eCG obtained from mares carrying 
intraspecific pregnancies also proved to be mostly ineffective in 
prolonging donkey pregnancies in mares. However, a dramatic 
improvement in such pregnancies was observed when recipient mares were 
immunized with parental donkey lymphocytes (Antczak and Allen, 1984). 
Allen et al. (1987) went on to find that such an immunization regimen 
was successful even if the lymphocytes were not of parental origin. 
Based on the results of donkey-in horse pregnancies, it has been 
proposed (Antczak and Allen, 1984; Allen et al., 1985) that antigens 
on the invading chorionic girdle cells stimulate a maternal 
immunoprotective response and if cup formation fails, the response 
remains unsolicited and immune rejection proceeds.
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Exotic Intersoecies Pregnancies
The phenomenon of interspecific and hybrid pregnancy is not 
limited to domestic species. As stated previously, there are a number 
of viable equine hybrids. One example is the Przewalski {Equus 
przewalski, 2n=66) x domestic horse (E. caballus, 2n=64) hybrid. The 
success of this cross led to embryo transfer attempts from endangered 
przewalskis to domestic mares (Hearn and Sumners, 1986; Sumners et 
al., 1987). Mary of the established interspecific pregnancies
developed to term and the presence of cytotoxic antibodies to parental 
antigens, as well as normal eCG levels in maternal sera, indicated 
normal endometrial cup formation. Perhaps more surprising is the 
successful transfer of Grant's zebra (E. burchelli, 2n=44) embryos to 
domestic horses (Bennet and Foster, 1985; Kydd et al., 1985; Hearn and 
Sumners et al., 1986; Sumners et al., 1987). Transfer of Grant zebra 
embryos to donkey recipients was also attempted (Kydd et al., 1985; 
Hearn and Sumners, 1986; Sumners et al., 1987) and pregnancies were 
established, but no live young were bom. One animal aborted her 
fetus at day 292 of pregnancy and exhibited symptoms of 
iirrnunologically based pregnancy toxemia syndrome. Pregnancy failure 
in the other recipients was characterized by very low levels of eCG 
produced for only a brief period of time suggesting poor endometrial 
exp formation and a strong cell-mediated cytotoxic reaction.
Among Bovidae there have been viable hybrid offspring produced, 
one example being the Zebu cattle (Bos indicus) x European domestic 
cattle (B. taurus) cross (Summers et al., 1983b). In addition, the 
American bison (Bison bison) will hybridize with European bison 
{Bison, bonasus), B. indicus, B. taurus and the Yak (Bos grunniens).
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Bovidae interspecific and intergeneric pregnancies established 
following embryo transfer have yielded variable results. A pregnancy 
resulting from the transfer of a B. taurus embryo to a water buffalo 
(Bubalus bubalus) was aborted ty 3 months of gestation and no 
pregnancies resulted from reciprocal transfers (Drost et al., 1986). 
Stover et al. (1981) reported the birth of a viable gaur calf (Bos 
gaurus) to a domestic cow recipient (23. taurus) following embryo 
transfer, however the other four recipients lost their pregnancies 
prior to term. In addition, the authors of this study reported 
abnormally low numbers of cotyledons on the allantochorion of both 
successful and aborted pregnancies indicating inappropriate placental- 
uterine tissue interaction. In contrast, reports of failed Dali's 
sheep (Ovis dalli dalli) pregnancies established following embryo 
transfer to domestic sheep (0. aries) indicated that there were no 
significant differences in cotyledon numbers (Buckrell et al., 1990). 
As there does not appear to be a specific characteristic associated 
with interspecific pregnancy failure, it has been difficult to predict 
and/or explain the success or failure of such pregnancies. However in 
most, if not all cases of interspecific pregnancy failure, 
immunological involvement is implicated. Nevertheless, the few 
successful exotic-in-domestic species pregnancies as well as the 
successful transfer of embryos between two exotic species such as the 
bongo antelope (Tragelaphus euryceros) to African eland (T. oryx) 
(Dresser et al., 1985) maintain interspecific embryo transfer as a 
potentially viable option for facilitating the propagation of 
endangered species.
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Embryo Manipulation
Perhaps the most convincing evidence supporting the hypothesis 
that the placenta is responsible for fetal allograft survival has been 
obtained from studies involving pre-implantation embryo manipulation. 
As embryos develop from morulae to blastocysts, the first irreversible 
cell differentiation occurs and two distinct cell lineages emerge, the 
inner-cell-mass (ICM) and the trophectoderm. The ICM cells continue 
to differentiate and become specialized, eventually completing the 
formation of the fetus. The trophectoderm, or trophoblast cells, 
possess the inherent ability to initiate implantation (Gardner et al., 
1973) and placental tissue is derived almost entirely from these 
cells.
In 1961, Tarkowski first reported that viable offspring could be 
produced from composite embryos derived from two aggregated eight-cell 
stage mouse embryos. Such offspring, containing cell populations of 
more than one genotype, are commonly referred to as chimeras. Over 
the past several years, a great deal of progress has been made 
concerning embryo manipulation. Methods for producing chimeras, other 
than ty embryo aggregation, were identified. For example, the 
blastocyst injection technique was described by Gardner et al. (1973) 
and later simplified ty Butler et al. (1987). This procedure involves 
the injection of an ICM isolated from one blastocyst into a recipient 
blastocyst. The end result is generally a chimeric fetus surrounded 
ty non-chimeric trophoblast.
Using blastocyst injection, Rossant and Frels (1980) injected M. 
caroli ICMs into M. musculus blastocysts and healthy, viable chimeric 
offspring were produced in M. musculus recipients. As this procedure
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ensured that the trophoblast, and thus the placenta, was derived from 
M. musculus cells, the recipients were prevented from immunologically 
rejecting the M. caroli cells contributing to the fetus proper. The 
importance of the trophoblast in maintaining interspecific murine 
pregnancies was further clarified when Rossant et al. (1982b) reported 
that the injection of M. musculus ICM into M. caroli blastocysts did 
not result in viable chimeric offspring if these composite embryos 
were transferred to M. musculus recipients. In addition, Papaioannou 
(1981) used a procedure known as blastocyst reconstitution, whereby 
the ICM of one blastocyst is completely replaced ty the ICM of 
another, to produce a M. caroli offspring surrounded ty M. musculus 
trophoblast carried to term in a M. musculus recipient. For fetal 
allograft survival, it appears to be imperative that the trophoblast 
and recipient are of the same species.
The success of chimeric and interspecific pregnancies following 
embryo manipulation is not restricted to the murine species. Such 
procedures have been applied to pre - implant at ion sheep and goat 
embryos over the past several years with results similar to those 
reported for mice. A number of scientists have produced interspecific 
sheep <-> goat chimeras ty aggregating cells from both sheep and goat 
embryos (Fehilly et al., 1984) and ty blastocyst injection (Fehilly et 
al., 1984; Polzin et al., 1986, 1987; Roth et al., 1989). In most 
cases, the manipulations were carried out in a manner that favored the 
development of trophoblast from cells of the same species as the 
recipient. However, it is worth noting that in cases of failed 
chimeric pregnancies, interspecific chimeric trophoblast was suspected
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and placental formation was characterized ty fewer placentomes 
(Anderson, 1988).
Blastomere aggregation and ICM injection are two techniques that 
have been used successfully in promoting true interspecific 
pregnancies. By combining blastomeres from embryos at slightly 
different stages of development, such that the ICM is derived mainly 
from one embryo and the trophoblast from the other, both goat-in-sheep 
(Meinecke-Tillman and Meinecke, 1984) and sheep-in-goat (Fehilly and 
Willadsen, 1986) pregnancies have teen carried to term. Similarly, 
interspecific injections of sheep ICM into goat blastocysts or goat 
ICM into sheep blastocysts have occasionally resulted in non-chimeric 
lambs bom to goats and kids bom to sheep (Fehilly et al., 1984; 
Polzin et al., 1987). Furthermore, the injection of sheep x goat 
hybrid ICM into sheep blastocysts followed ty their transfer to sheep 
recipients has resulted in sheep x goat hybrid <-> sheep chimeras 
(Roth et al., 1989). These results indicate that sheep x goat hybrid 
cells are viable and can contribute to the fetus and that hybrid 
pregnancy loss likely results from improper uterine-placental 
interactions, not aberrant fetal development.
While the significance of the placenta in protecting the fetal 
allograft is becoming well-established, the mechanism through which 
protection is mediated remains unclear. The theory that the placenta 
"masks" foreign fetal antigens from maternal immune recognition is 
flawed in that antibodies to fetal antigens are detected in the 
circulation of pregnant females. More specifically, antibodies to 
both allogeneic and xenogeneic antigens have teen identified in sheep 
and goats carrying interspecific, chimeric pregnancies (Ruffing et
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al., 1988). Even when ICM injection techniques are used such that 
non-chimeric trophoblast is ensured, the mother recognizes and 
responds, at least via humoral immunity, to xenogeneic fetal antigens 
(MacLaren et al., 1990).
Pertinent information concerning the irrsnuno-protective role of 
the placenta has been obtained from studies of hybrid and 
interspecific pregnancies as well as from experiments involving embryo 
manipulation. Despite the progress that has been made, there is no 
definite single answer to the proposed question concerning fetal 
allograft survival. Most likely, the mechanism responsible is 
complex, involving specific placental, uterine and immune system 
interactions that will require years of study to fully understand.
IMMUNOSUPPRESSION AND PREGNANCY 
Antibody Involvement
Following the establishment of immunoconpetency in pregnant 
fatales and the detection of maternal immune responses generated 
against fetal antigens, stronger interest was expressed in the theory 
that an immunosuppressive mechanism localized at the feto-matemal 
interface is responsible for fetal allograft survival. The presence 
of anti-fetal antibodies in serum of pregnant fatales has been 
discussed. The capacity of the placenta to act as an antigen- 
expressing "sponge" for absorbing these antibodies has been suggested 
(Raghupathy et al., 1981; Raghupathy et al., 1984), tut Bell and 
Billington (1983) found that the "sponge" activity of the placenta was 
ineffective when serum contained higher antibody titers. 
Alternatively, it has been suggested that anti-patemal antibodies
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which accumulate in and around the placenta (Hunziker et al., 1986) 
act as blocking antibodies. Such antibodies obtained from parous 
serum (Pavia and Stites, 1981; Hellstrom and Hellstrom, 1975) or 
eluted directly from the placenta (Bonneau et al., 1973; Faulk et al., 
1974; Stewart et al., 1984) are capable of suppressing lyrrphokine 
secretion, mixed lynphocyte reactions, and the generation of cytotoxic 
killer cells in vitro (Rocklin et al., 1979). However, the relevance 
of these blocking antibodies is questionable in light of the fact that 
not all successful pregnancies are associated with a humoral immune 
response (Lala et al., 1983) and thus, perhaps more important for 
fetal allograft survival, is a local suppression of cell-mediated 
immunity.
Suppressor Cells
Localized down- regulat ion of maternal cell-mediated immune 
responses could occur via recruitment/activation of suppressor cells 
or ty the production of soluble immunosuppressive factors. Supporting 
evidence for the former has been reported ty Clark and colleagues who 
have identified suppressor cells in uterine draining lymph nodes and 
decidual cells scraped from the gravid uterus (Clark et al., 1980). 
Two different populations have been identified as phase A and phase B 
cells (Slapsys and Clark, 1983). The phase A cells are produced in 
response to hormonal changes and prevent the generation of cytotoxic T 
lymphocytes (CTLs), but are only present during the preimplantation 
phase of gestation (Clark et al., 1980; Brierley and Clark, 1985). 
Phase B suppressor cells are described as non-T, non-B lymphocytes 
produced only when viable trophoblast is present. The absence of 
these cells is associated with failed Mus musculus x AT. caroli hybrid
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pregnancies (Clark et al., 1980; Clark et al., 1983). Phase B cells 
express antigen-non-specific suppressor activity which inhibits T cell 
activation in response to IL-2 (Clark et al., 1985). While these two 
types of suppressor cells may play an important role at the feto- 
matemal interface, their activity can be mediated ty a soluble factor 
of the decidua (Clark et al., 1984), indicating that the suppression 
of cell-mediated immunity in the uterus may ultimately be attributed 
to soluble factors produced ty the trophoblast.
Macrophage Involvement in Immunosuppression 
While many investigations have focused on lymphocytes as the 
target cell type for soluble immunosuppressors derived from the 
conceptus, there is some evidence that macrophages also play a role in 
suppressing immune reactivity in and around the placenta. Uren and 
Beyle (1990) recently reported that macrophages isolated from human 
placentae elicited only a low proliferative response from allogeneic T 
cells and failed to incite OIL function. The suppressive effect of 
these macrophages was not inhibited ty indamethacin, indicating the 
activity was independent of prostaglandin production. These results 
differ from those reported ty Scodras et al. (1990) who found that, in 
the mouse, decidual macrophages inactivated NK cells ty their 
production of FGE2.
Suppressor Activity of Prostaglandins and Hormones 
It has been well established that prostaglandins, especially 
PGE2 , are effective immunosuppressors. PGE2 is a feedback inhibiter 
of cellular immune functions and is produced ty suppressor cells 
(Goodwin and Ceuppens, 1985). Although PGE2 is produced in culture by 
embryos of numerous species including humans (Holmes et al., 1990),
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cows (Brang et al., 1988), sheep (Lacroix and Karin, 1984) and rabbits 
(Pakrasi and Dey, 1982), its role at the feto-matemal interface as a 
product of conceptus tissue is not well defined.
More attention has been focused on the potential significance of 
conceptus-derived, hormone-mediated suppression of immune function. 
Specifically, two steroid hormones, progesterone and estrogen, which 
play a critical role in the maintenance of pregnancy and are produced 
ty the conceptus (Heap et al., 1982; Dickmann et al., 1976; Flood et 
al., 1979) have been studied for their iimmoregulatory capacities.
In 1953, Black et al. first reported a decreased resistance to 
infection in the pseudopregnant rabbit uterus as corrpared to that of 
the estrus rabbit. However, it was many years later that truly 
compelling evidence for progesterone as a uterine immunosuppressant 
was reported. Moriyama and Sugawa (1972) demonstrated that, following 
progesterone treatment, xenogeneic cell survival in the hamster uterus 
was prolonged. Similarly, Siiteri et al. (1977) inplanted steroid 
containing silastic inplants into murine uteri and found that such 
treatment resulted in a local suppression of immunity and prolongation 
of xenogeneic skin grafts. In addition to these in vivo 
investigations, numerous in vitro studies have been carried out to 
characterize the immunoregulatory activity of progesterone. In 
general, the results indicate that progesterone inhibits mitogen 
activation of T lymphocytes when present in concentrations ranging 
from 10-20 jJM or greater (Shiff et al., 1975; Mendelsohn et al., 1977; 
Mori et al., 1977; Clemens et al., 1979), it inhibits T cell response 
to allogeneic cells in a MLR (Clemens et al., 1979) and can block the 
generation of CTLs directed against MHC antigens (Pavia and Stites,
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1981) when present at 1 to 3 fig/ml. However, progesterone can not 
affect CTL activity once the cells are produced, and progesterone is 
lethal to cells at 20 fig/ml (Siiteri and Stites, 1982). The 
significance of progesterone as a local irrmunosuppressor in utero is 
questionable considering only picogram-nanogram concentrations of 
hormones are secreted ty the conceptus in culture or found in 
blastocoelic fluid of embryos (Flood et al., 1979; Marsan et al., 
1987).
Estrogen has received much less attention as an immunoregulatory 
factor, partly because its effect on immune cell function is 
contingent on several factors. Estrogen can act as either a 
suppressor or an enhancer of immune function depending on 
characteristics of the host, such as age (Reilly et al., 1967), genome 
(Stem and Davidsohn, 1955), species (Nelson et al., 1967) and timing 
of immunization (Feigen et al., 1978). While results from in vitro 
studies with human lymphocytes have demonstrated the capacity of 
estrogen to suppress mitogen, antigen or allogeneic cell activation, 
as with progesterone, the levels of estrogen required were far above 
physiological concentration (Mendelsohn et al., 1977; Neifeld and
Tormey, 1979).
Soluble Suppressor Factors
Murine
The soluble placental factor responsible for inducing suppressor 
T cells during murine pregnancies was first partially characterized hy 
EXitchet-Suchaux et al. (1979). In 1984, Chaouat and Chaffaux 
reported that this factor, known as the Suppressor Inducer Factor 
(SIF), could induce suppressor cells in the Graft-vs-host reaction.
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Similar suppressor activities have been identified in supernatants of 
cultured murine blastocysts (Mayumi et al., 1985). Furthermore, it 
has been shown that supernatants from murine decidua can block mixed 
lynphocyte reactions (Chaouat and Kolb, 1984) and have effectively 
enhanced the survival of a murine heart allograft (Chaouat, 1987).
In addition to SIF, other irrmune modulatory factors associated 
with murine pregnancy have been identified. The resistance of 
placental tissue to lysis by natural killer cells and cytotoxic T 
lymphocytes is associated with the production of two distinct 
molecules that inhibit NK and CTL activity (Chaouat et al., 1985). 
There is evidence that NK cell infiltration into the decidua is 
associated with spontaneous abortion following matings of CBA female 
mice with DBA/2J males (Gendron and Baines, 1988). These findings may 
indicate a requirement for inhibiting NK cell activity to maintain 
successful pregnancies.
While placental-derived suppressor factors may be ultimately 
responsible for locally inhibiting the irrmune response in the uterus, 
they may be acting indirectly through the activation of suppressor 
cells responsible for suppression of cell-mediated irrmunity. The 
suppressor cells obtained from murine decidua secrete a 100,000 dalton 
factor that, in turn, blocks the response of T cells to IL-2 (Clark et 
al., 1985; Clark et al., 1986). In summary, murine decidua and/or 
conceptuses produce soluble factors that regulate immune suppressor 
cells. These cells produce soluble factors capable of interfering 
with cell-mediated irrmune responses.
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Human
While the murine species has been used most extensively in 
studies of placenta-derived, immunoregulatory molecules, a substantial 
quantity of information is available concerning similar factors in the 
human. Decidual cells obtained from endometrium of first trimester 
human pregnancies suppressed lynphocyte responses when supplemented to 
MLR cultures (Nakayama et al., 1985). In addition, the production of 
immunosuppressor factors ty pre-implantation embryos fertilized in 
vitro has been reported (Daya and Clark, 1986). These authors 
suggested that the detected production of suppressor factors from only 
43% of the embryos could, in part, explain the high percent of embryos 
lost very early in pregnancy.
Two suppressor factors associated with pregnancy in humans have 
received considerable attention. A specific factor known as placental 
protein 14 (PP14) was isolated from term human placentae in 1982 ty 
Bohn et al. and has since been shown to inhibit allogeneic MLR (Bolton 
et al., 1987) and PHA-stimulated lymphocyte proliferation (Pockley et 
al., 1988). Results from recent research indicate that the 
immunosuppressive activity of PP14 may be mediated ty the suppression 
of interleukin-1 (IL-1) secretion (Pockley and Bolton, 1990).
A second factor, known as pregnancy zone protein (PZP), is found 
on the surface of the chorionic villi (Stimson, 1977; Chemnitz et al.,
1982). PZP reportedly prolongs the survival of embryonal mouse heart 
allografts (Svendsen et al., 1978) and suppresses T cell blastogenesis 
in vitro, possibly ty reducing IL-2 production (Saito et al., 1990). 
However, the significance of PP14 and PZP as immunosuppressors is 
questionable considering they appear in maternal circulation during
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gestation (Julkunen et al., 1985), and systemic immunosuppression 
would be incompatible with healthy pregnancies.
Ungulate
Conceptus-derived immunosuppressive factors are not exclusively 
characteristic of decidual type placentae. Factors with similar 
activities have been reported in several large domestic ungulate 
species, sane of which possess epitheliochorial, cotyledonary 
placentae. Suppressor molecules have been obtained from uterine 
secretions of pigs (Murray et al., 1978), sheep (Segerson et al., 
1984; Hansen et al., 1987) and cows (Segerson and Libby, 1990) as well 
as fron supernatants of ovine and porcine conceptuses (Murray et al., 
1987). While all of the factors share the ability to suppress irrmune 
cell function, their immunoregulatory mechanisms and biochemical 
compositions differ.
Suppression of lymphocytes by bovine (Roberts, 1977) and porcine 
(Murray et al., 1978) uterine proteins was first reported many years 
ago. Murray et al. (1978) described the porcine suppressor proteins 
as small, acidic proteins (approximately 15,000 d) that were present 
in the uterus at day 15 of the estrous cycle. Subsequent research by 
other investigators focused more on pregnancy specific proteins and 
led to the identification of ovine trophoblast protein-1 (Godkin et 
al., 1984) and bovine trophoblast protein-1 (Godkin et al., 1988). 
These factors belong to the alpha-interferon family (Imakawa et al., 
1987; Stewart et al., 1987), exhibit immunoregulatory activity and are 
responsible for maternal recognition of pregnancy in their respective 
species. However, biochemically unrelated factors of a much higher
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molecular weight appear to be largely responsible for 
immunosuppressive activity in uterine/conceptus supernatants.
Segerson et al. (1984) purified two basic glycoproteins (UIM-P) 
with molecular weights of 57,000 and 59,000 from uterine milk of 
pregnant ewes (Days 125 and 130 of pregnancy). UIM-P inhibited 3H- 
thymidine uptake iy PHA-stimulated lymphocytes, was not cytotoxic and 
did not lose its activity with routine handling and storage. Further 
characterization of uterine milk proteins was carried out using gel 
filtration (Hansen et al., 1987). The authors reported that the basic 
protein fraction of uterine secretions contained the suppressive 
substance and that the substance was large (eluted in the void volume 
of Sephacryl S-200). Furthermore, the uterine secretions were 
obtained from non-gravid, ligated uterine horns of pregnant ewes, and 
thus the factors were identified as being of uterine, and not 
conceptus, origin.
In the same year, Murray et al. (1987) reported purifying a 
high-molecular-weight (MW >660,000) acidic glycoprotein (HMW3P) from 
medium of cultured day 16 and 17 porcine and ovine conceptuses. The 
HMWGP exhibited a tremendous ability to inhibit 3H-thymidine 
incorporation by PHA-stimulated lymphocytes, and this activity was not 
a result of cytotoxicity.
While a number of studies have been carried out to identify and 
characterize uterine- and conceptus-derived proteins, there is much 
less information available concerning the suppressive mechanisms of 
the numerous immunosuppressive factors associated with ungulate 
pregnancies. Recently, information concerning suppressive mechanisms 
has been obtained for ovine and bovine uterine luminal proteins (ULP)
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(Segerson, 1988; Segerson and Libby, 1990). As these proteins were 
obtained from uteri of pregnant animals, their specific origin 
(conceptus or uterine) is unknown. Both ovine and bovine ULP 
consisted of high (>248,000) and low (14,000-21,000) molecular weight 
suppressor factors (H-ULP and L-ULP, respectively). Ovine ULP 
suppressed IL-2 mediated blastogenesis of T lymphocytes and the author 
suggested that the suppressor mechanism was associated with an 
alteration of the IL-2 system. Bovine ULP involvement with IL-2 and 
the IL-2 receptor of T lymphocytes was more extensively investigated 
(Segerson and Libty, 1990). Using 125I-IL-2 the authors determined 
that L-ULP did not bind IL-2 tut H-ULP bound 70% of 125I-IL-2. 
Furthermore, a very high-molecular-weight (1.76 x 10^  MW) component of 
H-ULP bound 11.7% of 125I-IL-2 and inhibited binding of 125I-IL-2 to 
the IL-2R of cow lymphocytes.
Rationale of Present Research
Based on evidence indicating that: 1) the trophoblast plays a 
critical role in maintaining pregnancy, 2) the maternal immune 
response is under local suppression at the fetal-maternal interface of 
successful pregnancies and, 3) immunological rejection is responsible 
for failed interspecies pregnancies, we hypothesize that factors 
produced by the trophoblast are important in protecting the fetal 
allograft and that, during interspecific pregnancy, such factors from 
trophoblast of one species are frequently not capable of acting 
effectively on maternal immune cells of another species. To begin 
testing this hypothesis, the effect of soluble suppressor factors had 
to be characterized, first on allogeneic lymphocytes and subsequently
on xenogeneic lymphocytes, in order to identify any differences that 
may be responsible for interspecific pregnancy failure. In the first 
experiment, the suppressive activity derived from sheep, goat and 
sheep x goat hybrid trophoblast was examined to determine if a 
decreased suppressive capacity of hybrid tissue could he associated 
with failure of hybrid pregnancies. Subsequent studies were carried 
out with horse conceptuses and trophoblast tissue. The results of 
this research indicate that, similar to that of other species studied, 
horse trophoblast tissue secretes high-molecular-weight soluble 
factors capable of inhibiting maternal immune cell function. A 
>100,000 MW horse trophoblast tissue-derived suppressor factor was 
identified. The fact that this factor is produced fcy embryos as early 
as day 9 and as late as day 26 of gestation, exhibits sane degree of 
species-specificity and acts specifically on T lymphocytes, supports 
our initial hypothesis. The characterization of this suppressor 
factor's effect on T cell expression of the IL-2R provides valuable 
insight into the suppressive mechanism of this factor. These results 
increase our understanding of the fetal-maternal immunological 
relationship in the horse and, because these findings are compatible 
with those reported for other species, it seems likely that the events 
responsible for fetal allograft protection are largely conserved 
across species. Therefore, the results of these studies are a 
significant contribution to the pool of information available to those 
trying to determine the cause of interspecific pregnancy failure 
and/or immune-mediated recurrent abortion. In addition, identification 
of the suppressive mechanism associated with this suppressor factor 
provides critical information that may be useful in future attempts to
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treat recurrent abortion and to facilitate the survival of 
interspecific pregnancies ty altering maternal immune function in 
utero.
CHAPTER IX
SUPPRESSION OF SHEEP AND GOAT LYMPHOCYTE 
PROLIFERATION BY SHEEP, GOAT AND SHEEP X GOAT HYBRID 
TROPHOBLAST TISSUE CULTURES1 
INTRODUCTION
The role of the mammalian placenta in protecting the fetal 
allograft during pregnancy has not been clearly defined. Although 
placental tissue expresses antigens early in development (Pavia et 
al., 1981; Allen et al., 1986; Billington and Burrows, 1986) and the 
maternal immune system may generate anti-fetal antibodies (Allen et 
al., 1987; MacLaren et al., 1990), intraspecies pregnancies proceed 
uninterrupted. It has been suggested that conceptus-derived 
immunosuppressor factors help protect the fetus from immunological 
rejection (Mayumi et al., 1985; Clark et al., 1986; Daya and Clark, 
1986; Murray et al., 1987; Crcy et al., 1988; Roth et al., 1990). The 
protective mechanism normally involved during intraspecific gestation 
seams to be ineffective in interspecific and hybrid pregnancies of 
same closely related species (McGovern, 1975; Frels et al., 1980; 
Clark et al., 1984). For example, the domestic sheep (Ovis aries) x 
goat (Capra hircus) hybrid pregnancy is usually maintained for only 30 
to 45 days and there is evidence for immunological involvement in the 
loss of such pregnancies (Hancock et al.,1968; Dent et al.,1971; 
McGovern,1973).
This study was designed to determine if medium conditioned with 
trophoblast tissue of 20 day-old sheep x goat hybrid conceptuses
1 Roth, T.L., K.L. White and D.W. Hordhov. J. Anim. Sci. (In press).
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suppresses sheep and(or) goat lymphocyte proliferation, and to compare 
hybrid suppressor activity to that of sheep and goat conceptuses.
MATERIALS AND METHODS
Animals. Ovine conceptus donors were Suffolk ewes bred to 
Merino rams. Does that served as both caprine and hybrid conceptus 
donors were of various mixed breeds. A Nubian tuck and Barbados rams 
were crossed with does to produce caprine and hybrid conceptuses, 
respectively.
Superovulation and Breeding Regimen. Estrous cycles of 4 
ewes and 8 does were synchronized by inserting intravaginal pessaries 
containing 60 mg depo-provera (Upjohn, Kalamazoo, MI) for 10 days. To 
superovulate donors, FSH (Schering Corp., Kenilworth, NJ) was 
administered every 12 h for 3 days in decreasing doses of 4,4; 3,3 and 
2,2 mg, respectively, starting 1 day prior to pessary removal. Donors 
received an injection of .25 pg Cloprostenol (Estrumate, Bay Vet, 
Shawnee, KS) coinciding with the second FSH injection.
Animals were observed for estrus twice daily starting on the 
last day of FSH injections (day 0). Estrous ewes and 4 estrous does 
were bred ty rams and bucks, respectively, every 12 h until no longer 
in estrus. Similarly, the 4 hybrid donor does were allowed to breed 
naturally with Barbados rams every 12 h until the end of estrus. To 
ensure only pregnant donors underwent laparotomies, all mated donor 
animals were observed for a return to estrus starting 16 days 
following the last FSH injection. Animals were checked twice daily 
until the day of conceptus collection (day 20).
Conceptus Collection and Culture. Conceptuses were 
collected at laparotomy from ewes and does 20 d following their last
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FSH injection (day 0). Only those animals that had been in estrus on 
day 0 were used. Phosphate buffered saline (PBS) supplemented with 1% 
calf serum (Hyclone, Logan, UT) and 1% antibiotic/antirrycotic was used 
to flush pregnant uteri. PBS was injected into the uterine bod/ at the 
base of each horn and conceptus tissue was collected via retrograde 
flushing through a glass cannula (12 mm i.d.) inserted into the tip of 
the uterine horn. Conceptuses were collected from nine animals, three 
donors of each conceptus type (caprine, ovine and hybrid). Conceptuses 
were immediately rinsed three times in sterile PBS and all fetuses
were removed from tissue. Tissue was rinsed once in RHYH-1640
(Hyclone, Logan, UT) supplemented with 1% antibiotic/antirrycotic and 
15% fetal calf serum (Hyclone, Logan, UT; non-heat-treated, <0.1 ng/ml 
endotoxins) (RPMI+) and was divided into two or three approximately 
equal sections. Each tissue section was placed in a tissue culture 
flask (25 cm2) containing 15 ml RFME+. Conceptus tissue cultures were 
incubated at 37°C in a humidified atmosphere of 5% CO2 and air for 24 
h. To obtain trophoblast tissue-conditioned medium, the content of 
each culture was poured into a 15 ml conical centrifuge tube and
centrifuged (600 x g; 30 min). Supernatant was filtered through a .22 
Urn filter and was stored in 1 ml aliquots at -80°C. The tissue from 
each culture was blotted dry and weighed. Average weights for sheep 
(n=3), goat (n=3) and lybrid (n=3) tissues were .34, .33 and .34
gm/flask, respectively.
Lymphocyte Proliferation Assay. Whole blood was collected 
into heparinized tubes by jugular venipuncture from 4 randomly chosen 
ewes and does. The blood was diluted with an equal volume of Hank's 
basic salt solution (HBSS; Hyclone, Logan, UT) and 7 ml of the
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blood/HBSS mixture was layered over 4 ml Ficoll-Paque (Pharmacia, 
Piscataway, MJ). Following centrifugation in a 15 ml centrifuge tube 
(550 x g; 30 min), the interface cells were collected and washed twice 
with HBSS. The cell pellet was resuspended in R3FMI+ medium, cells were 
counted on a hemacytometer and cell suspensions were diluted with 
REMI+ to 4 x 106 cells/ml.
Lymphocyte cultures were carried out in triplicate in 96-well 
round-bottomed tissue culture-treated plates (Coming Glass Works, 
Coming, NY). All wells received 1 x 105 cells (25 jll). Non-stimulated 
and stimulated controls received 75 and 50 (Xl REMI+, respectively, and 
stimulated controls also received 25 jll REMI+ containing .1 jig FWM. 
Experimental wells were supplemented with 6, 3, 1.5 or .75 jll of 
caprine, ovine or hybrid conditioned medium (CCM, OCM and HCM, 
respectively) diluted in 50 jll REMI+. For each type of conditioned 
medium, samples of three cultures obtained from three different donors 
were tested. All experimental wells also received 25 jll aliquots of 
RHMI+ containing .1 jig PWM. Total volume in all wells was 100 jll. All 
cultures were carried out simultaneously using the same cell 
suspensions and cultures were maintained at 37^ in a humidified 
atmosphere of 5% CQ2 and air. 3H-thymidine (1 jiCi/well; 6.7 Ci/mmol, 
ICN, Irvine, CA) was added to cultures 96 h after the start of 
incubation, and cells were harvested at 112 h with a Skatron automatic 
cell harvester (Flow Laboratories, Rockville, MD). Radioactivity, a 
measure of cell proliferation, was determined by liquid scintillation 
counting. Prior to harvest, percent cell viability was determined in 
wells of each treatment group by trypan blue exclusion.
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Statistical Analysis. Data reported as percent of stimulated 
control was calculated for triplicate wells using the equation (% 
control = average cpn of experimental cultures / average cpm of 
stimulated control cultures X 100). Results were analyzed in a 3 x 4 
factorial ANOVA. (3 conceptus types and 4 volumes of conditioned 
medium) using the general linear model procedures of the statistical 
analysis systems (SAS) computer package (Luginbuhl et al., 1985). 
Randan variables were lynphocytes and conceptuses. Highly 
insignificant (P>.75) interactions were deleted from the model and 
appropriate error terms were used to test the main effects, i.e. 
variation attributed to species of lymphocyte was tested with the 
error term lymphocyte within species and variation due to type of 
conceptus was tested using conceptus within type. Tukey's mean 
comparison tests were used to compare the effects of different volumes 
of conditioned medium and to determine differences between sheep and 
goat lymphocyte suppression within CCM, HCM and OCM treatment groups.
RESULTS
The superovulation and breeding regimen proved effective in 
that, with the exception of one goat conceptus donor, all donor 
animals exhibited numerous corpora lutea and multiple conceptuses were 
obtained from each animal. When compared to goat and sheep 
conceptuses, hybrid conceptus tissue appeared healthy and fetal 
development normal, indicating that failure of hybrid pregnancy had 
not yet occurred.
Medium conditioned with ovine, caprine and hybrid trophoblast 
tissue suppressed (Pc.01) both sheep and goat FWM-stimulated 
lymphocyte proliferation in a dose-dependent manner (Figures 1 and 2).
Conditioned Medium Added (jil/well)
Figure 1. The effect of caprine, ovine and hybrid 
trophoblast tissue-conditioned medium (CCM, OCM and HCM, 
respectively) on PWM-stimulated sheep lymphocyte 
proliferation. Values representmean percent of stimulated 
control i SEM (n=12). Overall suppressor activity did not 
differ (P>.05) between treatments.
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Figure 2. The effect of caprine, ovine and hybrid 
trophoblast tissue-conditioned medium (CCM, OCM and HCM, 
respectively) on PWM-stimulated goat lymphocyte 
proliferation. Values represent mean percent of stimulated 
control — SEM (n=12). Overall suppressor activity did not 
differ (P>.05) between treatments.
45
The overall suppressor activity of CCM, OCM and HCM on lymphocytes of 
either sheep or goats did not differ (P>.05). Data corrparing sheep and 
goat lymphocyte proliferation within each type of conditioned medium 
are in Table 1. The results indicate that proliferation of sheep 
lynphocytes was suppressed more than that of goat lymphocytes when 
treated with CCM, OCM or HCM (Pc.Ol, Pc.Ol and P<.05, respectively). 
Viability of lynphocytes at the end of culture was consistently 85-95% 
across all treatments.
DISCUSSION
Evidence supporting the theory that the placenta plays an 
important role in maintaining the fetus as an allograft in the mother 
has been obtained through the use of embryo manipulation techniques. 
The injection of embryonic cells from one species into blastocysts of 
a different species can result in successful interspecies pregnancies 
provided the placenta and recipient are of the same species (Rossant 
et al., 1982; Fehilly et al., 1984; Meinecke-Tillman and Meinecke, 
1984; Polzin et al., 1987). This technique has been used to produce 
healthy offspring containing sheep x goat hybrid cells (Roth et al.,
1989). These results indicate that the hybrid placental tissue, not 
the fetal cells, is responsible for the failure of sheep x goat hybrid 
pregnancies. One explanation for this failure may be a deficiency in 
the ability of hybrid trophoblast tissue to create and maintain an 
immunosuppressive environment at the fetal-maternal interface.
While there have been a number of reports concerning 
immunosuppressive activity in ovine uterine fluid during intraspecies 
pregnancies (Hansen et al., 1987; Segerson et al., 1984; Segerson, 
1988), there has been less published data pertaining to ovine
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TABLE 1. Suppression of PWM-stimulated sheep and 
goat lymphocyte proliferation by caprine, hybrid and 
ovine trophoblast tissue-conditioned medium (CCM, 
HCM and OCM, respectively)a.
Conditioned medium^
Medium Goatd
______ Jarvr* ,
Goatd
( f i l / w e l l )
.75 51.6  ±  2 .6 68.8 ±  1 .5 37.3 ±  3 .2 49.2 ±  1.2 39.1 i  4.3 53.7 ±  3.3
1.5 37.3  ±  1 .9 54.7 ±  2 .3 21.2 ±  1.7 35.6 ±  1.8 25.8 ±  2 .7 41.8 ±  2.8
3 23.8  ±  2 .4 38.5 ±  2 .5 10.3 ±  1.8 26.1  ±  3.1 15.5 ±  2 .7 32.8 ±  3.1
6 12.0 ±  1 .1 23.3  ±  2 .0 5.3  ±  1.0 14.1 ±  2 .0 9.0 ±  1.7 22.3  ±  2 .4
aValues represent (mean ± SEM) percent of sheep (n=4) and 
goat (n=4) stimulated controls (109,000 and 183,000 cpm, 
respectively). Non-stimulated control (background) values 
for sheep and goat were 5,330 and 6,100 cpm, respectively.
^Medium conditioned by the 24 h culture of 20 d-old caprine, 
hybrid and ovine trophoblast tissue (CCM, HCM and OCM, 
respectively).
cTukey's mean comparison test was used to determine 
differences in overall sheep and goat lymphocyte 
proliferation within the conditioned medium.
Suppression of goat lymphocyte proliferation was less 
(P<.01) than that of sheep lymphocytes.
Suppression of goat lymphocyte proliferation was 
(P<.05) than that of sheep lymphocytes.
less
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conceptus-derived suppression (Murray et al., 1987; Staples et al., 
1983) and information is lacking regarding that of the sheep x goat 
hybrid conceptus. In this study, we focused on the production of 
irmtunosuppressor factors hy the developing placenta. The cultures 
contained conceptus trophoblast tissue devoid of the amnion, which was 
discarded with the fetus. Therefore, the immunosuppressive activity of 
CCM, OCM and HCM, reported herein, was derived specifically from early 
placental tissue of 20 day-old goat, sheep and sheep x goat hybrid 
conceptuses, respectively.
Conceptuses were collected on day 20 of gestation for two 
primary reasons. First, because hybrid pregnancy loss occurs between 
days 35 and 45 of gestation (Hancock et al., 1968; Tucker et al., 
1971; McGovern, 1973) and has been reported as early as day 30 
(Hancock et al., 1968), we wanted to ensure that healthy conceptus 
tissue was obtained. Our collection of numerous, apparently normal 
hybrid conceptuses was not unexpected as others have reported normal 
hybrid fetal and placental development until day 30 to 35 of pregnancy 
(Hancock and Jacobs, 1966; Hancock et al., 1968), beyond which 
excessive lymphocyte infiltration (Hancock et al., 1968) and increased 
allantoic fluid accumulation occurs (McGovern, 1977). The second 
reason for collecting day 20 conceptuses was based on the hypothesis 
that these reported abnormal characteristics result from a disruption 
of the immunoregulated uterine environment. Such a disruption would 
likely occur some time prior to the manifestation of these 
abnormalities. Therefore, if conceptus-derived suppressor factors are 
involved with controlling uterine immune function, there may be some
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change in the immunosuppressive competence of the hybrid conceptus as 
early as day 20 of gestation.
The results of this study indicate that HCM effectively 
suppressed in vitro sheep and goat lymphocyte proliferation and, 
therefore, the findings fail to support the hypothesis that a lack of 
conceptus-derived immunosuppressive activity precedes rejection of the 
hybrid conceptus. However, a decrease in immunosuppressive activity 
may occur closer to the time of fetal death and simply cannot be 
detected on day 20 of gestation. Alternatively, the production and (or) 
functions of conceptus-derived suppressor factors may be altered while 
in vivo via fetal-maternal tissue interactions, tut once removed from 
the uterine environment and placed in culture, the production and (or) 
functions of these factors resume. Finally, it is possible that 
suppressor factors are consistently produced during early hybrid 
gestation, but other events lead to maternal lynphocyte escape from 
suppression and, perhaps, to their attack of the hybrid conceptus.
Maternal lynphocyte evasion of suppression may be mediated via 
strong antigenic stimulation. Xenogeneic antigens expressed on hybrid 
and interspecific placental tissue may have more stimulatory impact on 
the maternal immune system than allogeneic fetal antigens, thereby 
disrupting the seemingly compatible fetal-maternal relationship that 
normally exists during intraspecific pregnancy. Although much is still 
unknown about this intimate relationship between maternal and fetal 
tissue, in the two most intensively studied models of interspecies and 
hybrid pregnancy (murine and equine) the immune response seams to play 
an integral role in implantation and placentation. Murine embryo 
inplantation is associated with lynphocyte accumulation at the fetal-
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maternal interface (Slapsys and Clark, 1982; Slapsys and Clark, 1983) 
tut only in unsuccessful interspecies or hybrid pregnancies does the 
trophoblast become infiltrated with lynphocytes (Cray et al., 1982). 
m  intraspecific equine pregnancies, lynphocytes accumulate around the 
endometrial cups tut do not penetrate into the cup tissue until days 
70 to 80 of gestation (Allen, 1982). However, in equine hybrid 
pregnancies, lynphocyte invasion of the cups occurs much more rapidly 
with complete loss of endometrial cips occurring at day 60 (Allen, 
1969; Allen, 1982). Similarly, the excessive lynphocyte infiltration 
observed in sheep x goat hybrid pregnancies (Hancock et al., 1968) is 
in contrast to a noted decrease in accumulated uterine lynphocytes 
following attachment of the conceptus in intraspecific ovine 
pregnancies (King et al., 1982). Together, these data may indicate a 
local suppression of the maternal immune cells at the fetal-maternal 
interface is ineffective in hybrid and interspecific pregnancies 
probably due to a disruption of suppressor activity and (or) an 
overriding irrmune response against xenogeneic antigens. At day 20 of 
pregnancy, the ovine and caprine conceptus has attached (Leiser, 1975; 
King et al., 1982) but interdigitation of chorionic microvilli in 
developing placentomes does not occur until the fourth week of 
gestation (Boshier, 1969; Dent, 1973). As this event is likely to 
provide the antigenic stimulation that may initiate changes leading to 
maternal immunological rejection, it is possible we obtained 
conceptuses prior to any immunological alterations in the uterine 
environment that could affect subsequent placental suppressor 
activity.
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HCM suppressed sheep and goat lynphocytes as effectively as OCM 
and CCM. However, it is important to point out that FWM was used to 
stimulate lynphocyte proliferation and, in a previous study involving 
horse conceptus-derived suppression, Roth et al. (unpublished data) 
found that PSMI-stimulated lynphocytes were easier to suppress than 
phytohemagglut inin- or lipopolysaccharide-stixnulated lynphocytes. 
These results indicate that the type of antigen stimulating the 
lynphocytes plays a role in determining the extent to which 
proliferation is suppressed by conceptus suppressor factors. In utero, 
lynphocytes stimulated by hybrid placental xenoantigens may be more 
difficult to suppress than those stimulated with intraspecific fetal 
alloantigens. Therefore, the apparent equality of suppressive activity 
of HCM, OCM and CCM in in vitro FWM-stimulated lynphocyte assays may 
not be an accurate assessment of the in vivo situation. Unfortunately, 
an in vivo analysis of lynphocyte-conceptus tissue interaction was 
beyond the scope of this study.
The reported difference between sheep and goat lynphocyte
suppression within each treatment (Table 1) is likely a reflection of 
the difference in species responsiveness to the PWM. To ensure
consistency across all assays, the same PWM concentration (.1 i^g/well) 
was supplemented to all stimulated cultures. This concentration is one 
that provokes a strong proliferative response in lynphocytes of both 
species. However, when a mitogen titer assay was carried out for goat 
and sheep lynphocytes, the optimal lynphocyte responses were achieved 
using .1 and .2 jog/well, respectively (unpublished data). Thus, the 
PWM dose used in the assay was slightly suboptimal for sheep
lynphocytes, which may explain the lower stimulated control values and
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the greater suppression of sheep lynphocytes with CCM, OCM and HCM 
when compared to that of goats.
In summary, superovulation of does followed by natural mating 
with Barbados rams may result in numerous hybrid conceptuses with 
apparently normal fetal development and healthy trophoblast tissue at 
day 20 of gestation. Medium conditioned with hybrid trophoblast tissue 
will suppress proliferation of EWM-stimulated sheep and goat 
lynphocytes. No differences between suppressive activity of CCM and 
OCM or HCM obtained from 20 day-old conceptuses was determined. These 
results indicate that, at day 20 of gestation, sheep x goat hybrid 
trophoblast does not differ from ovine or caprine trophoblast in its 
ability to suppress PlM-stirnulated lynphocytes.
CHAPTER III 
SUPPRESSION OF LYMPHOCYTE PROLIFERATION 
BY A >30,000 MW FACTOR IN HORSE 
CONCEPTUS-CONDITIONED MEDIUM2
INTRODUCTION
The mechanism by which the fetal allograft escapes maternal 
immunological attack during pregnancy remains largely unknown. It is 
well documented that fetal tissue in intimate contact with uterine 
epithelium expresses antigens early in development (Chatterjee- 
Hasrouni and Lala, 1981; Pavia et al., 1981; Allen et al., 1986). The 
maternal immune system recognizes the fetal antigens and frequently 
responds with a humoral immune response. Antibodies against fetal 
antigens are present in the maternal circulation of up to 90% of 
pregnant mares (Allen et al., 1987). A cell-mediated immune response 
also seems to occur at the fetal-maternal interface, and may even be 
essential for proper implantation (Beer et al., 1975). These 
immunological events have no detrimental effects on the fetus or 
placenta of natural intraspecific pregnancies. Yet with many 
interspecific or hybrid pregnancies, the protective mechanism normally 
involved during gestation seems to be ineffective, and abortion 
generally occurs (McGovern, 1975; Clark et al., 1984). The production 
of chimeric embryos, resulting in a placenta derived mainly from an 
embryo of the recipient maternal species and the fetus originating 
from a different species or hybrid embryo, makes it possible to 
produce offspring from recipients that will not otherwise carry the
2 Roth, T.L., K.L. Mute, D.L. Thorpson, Jr., B.E. Barry, J.S. Capehart, D.R. Colbom 
and M.H. Rabb. 1990. Biol. Reprod. 43:298-304.
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fetus to term (Rossant et al., 1982; Fehilly et al., 1984; Polzin et 
al., 1987; Roth et al., 1989). During such chimeric pregnancies, 
antibody titers against xenogeneic and allogeneic antigens have been 
identified in maternal circulation, yet the fetus remains unharmed and 
is successfully carried to term (Ruffing et al., 1988; McLaren et al.,
1990). Hence, it seems possible that the placenta plays a role in 
blocking maternal immunological attack (tut not recognition) of the 
fetus, and that the placenta must he of the maternal species in order 
to efficiently perform this protective mechanism.
Interest in the potential role of the conceptus in regulating 
maternal immune function has led to the identification of conceptus- 
derived products with immunoregulatory functions in several domestic 
species (Clark et al., 1986; Murray et al., 1987; Cray et al., 1988; 
Pandian et al., 1988). Seme products have been identified as 
interferons (Cross and Roberts, 1989) and are responsible for maternal 
recognition of pregnancy (Roberts et al., 1985). Others have been 
identified as immunosuppressive factors when tested in vitro, but 
their exact mechanism of action or significance in vivo has yet to be 
elucidated. If these suppressor factors play a critical role in 
protecting the conceptus from immunological attack, then their 
inability to act effectively across species' lines may provide an 
explanation for early loss of interspecific pregnancies. In this study 
we have identified an immunosuppressive substance produced by the pre­
implantation horse conceptus and have determined sane of its 
characteristics. Furthermore, we have examined the suppressive 
activity of this substance on lynphocytes of other species.
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MATERIALS AMD METHODS 
Animals and Embryo Collections. Fifty-five mares of 
various lighthorse breeds were teased daily by stallions to identify 
those in estrus. Estrous mares were artificially inseminated with 
fresh, raw semen (5 x 106 progressively motile sperm) on the second 
day of estrus and every other day thereafter until ovulation 
(determined by daily palpation and/or ultrasonography). Conceptuses 
were collected at three stages of gestation: Group I - day 9-10, Group 
II - day 15-16 and Group III - day 25-26 (ovulation = day 0). A total 
of six Group I conceptuses were collected from six different mares by 
the non-surgical embryo collection procedure previously described by 
Imel et al. (1981). Ultrasonography was used on day 12 to determine 
pregnancy in Group II and III conceptus donor mares. Three Group II 
and III conceptuses from six different mares were recovered ty a 
modified non-surgical uterine flushing technique. Mares were lightly 
sedated with 1-3 ml Rompun (Mobay, Shawnee, KS) administered iv five 
minutes prior to initiating the flushing procedure. The mare's cervix 
was mechanically dilated ty digital palpation. Sterile tygon tubing 
(18 mm i.d.) was inserted into the vagina and manipulated through the 
dilated cervix into the uterine body. Throughout the procedure the 
cervix was held firmly around the tubing to maintain the tubing's 
position and to prevent fluid leakage from the uterine body out of the 
relaxed cervix. Sterile PBS supplemented with 1% 
antibiotic/antimycotic and 1% calf serum was poured into the external 
end of the tubing. Gauze was placed over the exposed end of tubing and 
air was blown in, forcing the fluid into the uterus. This process was
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repeated until no more fluid would enter the uterus. The gauze was 
removed and the uterine effluent was collected into a sterile flask.
Conceptus Cultures. All conceptuses were rinsed under 
sterile conditions five times with RPMI+ and were placed in tissue 
culture flasks containing RR4I+ as follows: Group I - two embryos/4
ml, Group II - one conceptus/12 ml and Group III - one conceptus/30
ml. All cultures were incubated at 37°C in a humidified atmosphere 
containing 5% C02 and air. RFMI+ cultured alone served as control 
medium (CM). Cultures were terminated at 24 ± 1 h. Horse conceptus 
conditioned medium (HCCM) was obtained from cultures, centrifuged at 
1500 x g for 20 min and filtered through a .2 pm filter.
Lymphocyte proliferation assay. Heparinized whole blood, 
obtained by jugular venipuncture from 3 randomly chosen mares served 
as a source of peripheral blood lymphocytes (PELs). Blood from each 
animal was separately mixed with an equal volume of HBSS. Ten ml of 
the blood-HBSS mixture were layered over 4 ml Ficoll-Paque in a 15 ml 
conical tube and samples were centrifuged for 20 min at 500 x g. 
Interface cells from each horse were pipetted into separate centrifuge
tubes and rinsed twice with 8 ml HBSS (400 x g; 10 min). The
peripheral blood mononuclear cells were resuspended in RPMI+, counted 
on a hemacytometer and diluted to a final concentration of 4 x 106 
cells/ml. Cultures were carried out in triplicate in 96-well round- 
bottom tissue culture treated plates. All wells received 1 x 10^  cells 
(25 |Xl). Stimulated cultures received 25 jll aliquots of RPMI+ 
containing one of three mitogens: 1 jig PHA, 1 jig PWM or 5 jig Con A. 
HCCM from Groups I and II was tested on T cell mitogen (PHA and Con A) 
stimulated lymphocytes to ensure that the observed suppression was not
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EV2M or B cell specific. In addition to mitogen, experimental wells 
received 0, 25 and 50 Jll HCCM while control wells received similar 
quantities of CM. Mon-stimulated cultures contained cells in REMI+ 
only. All wells contained a final volume of 100 Jll. Each of the three 
HCCM samples in each of groups I-III was tested on PBLs from 3-4 
randomly chosen mares. Cultures were maintained in an incubator at 
37°C in a humidified atmosphere with 5% C02 and air. ^H-thymidine was 
added to cultures (1 Jici/well) at 96 i 2 h and cells were harvested 16 
1 2 h later onto glass fiber filters using a Skatron automatic cell 
harvester. Radioactivity on the filters was determined by liquid 
scintillation counting. Prior to harvest, percent cell viability in 
control and experimental cultures was determined by trypan blue 
exclusion.
HCCM Characterization. Characterization tests were carried 
out with a pool of HCCM derived from three 2 0-day conceptuses 
collected and cultured for 48 h as described above, each in 20 ml 
RFMI+. After centrifugation and filtration, the sample was stored at - 
80°C in 1.5 ml aliquots. RIMI+ alone was cultured and stored 
identically to serve as CM for all treatments. To further decrease 
intra- and inter- assay variability and to increase assay sensitivity, 
mitogen titer assays were run on lynphocyte donors to determine the
optimal mitogen dose for each donor. PWM was serially diluted from 4
to .05 fig/well and three mares responding optimally to the same
mitogen dose of .2 jig/well served as PBL donors for all subsequent
assays with EVM as the stimulating mitogen. For heat-treatment (HT), 
aliquots of HCCM and CM were thawed to room temperature, and a 600-jxl 
sample of each was placed in a sterile glass vial and held in a beaker
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of water at 90°C for 30 min. Freeze-thaw treatment (FT) consisted of 
placing 600 fi.1 HCCM and CM each in a 1 ml cryovial and freezing to - 
80°C, followed by thawing to room temperature for a total of eight 
cycles. Two other 600-fil samples of HCCM and CM were filtered two 
times each through a .2 }im nitrocellulose filter (NCF). A final 600-|il 
untreated fresh-frozen (FF) sanple of each HCCM and CM was conpared to 
treated samples. Serial dilutions of all HCCM and CM samples were made 
with RFMI+ and samples were added to lynphocyte cultures at .75, 1.56, 
3.23, 6.25, 12.5 and 25 p.l/well (total well volume = 100 (Xl). To 
identify the approximate size of the substance causing suppression, 
500 (ll samples were centrifuged at 4500 RTM for 30 min. through amicon 
microconcentrators (Amicon, Danvers, MA) with MW exclusions of 10,000 
and 30,000. Sanple concentrates were rinsed ty diluting with 500 (J.1 
REMI-1640 and spinning again at 4500 RTM for 30 min. Concentrate was 
again diluted back to its original 500 |ll volume with REMI-1640. The 
two MW fractions of HCCM and CM were added to lynphocyte proliferation 
assays in quantities of 2, 4 and 8 (ll sanple/well to test for
suppressive activity.
Interspecies Assay. The suppressive effect of HCCM on goat, 
donkey and horse lynphocytes was conpared. FWM-titer assays as 
described for horse PBL donors were used to screen potential goat and 
donkey PBL donors. Three does and three jennies with optimal responses 
at .2 pg/well FWM were chosen for the interspecies assay. EVJM- 
stimulated lynphocyte proliferation assays were set up as described 
previously with lynphocytes from the three chosen PBL donors of each 
species and with HCCM or CM added at .4, .8, 1.6 , 3.2 , 6.4 and 12.8 
l^l/well (total well volume = 100 (J.1).
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Statistical Analysis. Average cpm and % of stimulated
control for triplicate or quadruplicate wells were determined. Results 
(cpm) from the addition of HCCM of Group I, II and III cultures to 
lynphocyte proliferation assays were analyzed ty ANOVA using the 
general linear model procedures of the SAS computer package (Luginbuhl 
et al., 1985) to determine suppressive activity of HCCM. Linear and 
quadratic contrasts were used to determine the relationship between 
the addition of 0, 25 and 50% HCCM and percent suppression. HCCM 
induced suppression was conpared between groups by Tukey's mean 
conparison tests. Results from treated HCCM and interspecies assays 
were expressed as average cpm and/or percent of stimulated control and 
were similarly analyzed ty ANOVA and Tukey's mean comparison tests. 
Polynomial regression analysis was used to conpare suppressive 
activity curves in the interspecies assay.
RESULTS
Groups I-1II. When supplemented to cultures at 25% or 50% of
the total well volume, HCCM from Groups I, II and III suppressed 
lynphocyte proliferation (Pc.001) induced ty PWM, while CM exhibited 
no suppressive activity (P>.05) when similarly added to cultures 
(Table 2). In all groups, there was a linear relationship (P<.01) 
between % suppression and the addition of 0, 25 and 50% HCCM. HCCM 
also suppressed lynphocyte stimulation (P<.001) induced ty Con A and 
PHA when added to cultures at 25% and 50% of well volume. Viability of 
cells in experimental wells was always 85-95% at the end of the 
culture period.
59
TABLE 2. Effect of control medium and HCCM from
Groups I-III on mitogen-stimulated horse PBL
proliferation.a
Mitogen —St xmulat ion
Source of
Medium l&Yfill -Jaonfi_  PWM*> ConAc  PHa£-
Group I 0 6,896 ± 2,299
(Day 9-10) 0 37,504 ± 6,240 39,260 ± 4,423
25 21,745 ± 3,986* 19,882 ± 3,198*
50 19,312 ± 3,668* 17,816 ± 2,843*
Group II 0 35,286 ± 5,377
(Day 15-16) 0 85,480 ± 5,724 53,783 ± 4,431
25 22,547 ± 5,067* 23,647 ± 3,971*
50 9,766 ± 2,428* 11,349 ± 2,262*
Group III 0 14,018 ±2,194
(Day 25-26) 0 61,899 ± 5,384
25 33,193 ± 6,179*
50 19,975 ± 4,706*
Control
Medium 0 6,896 ±2,299
0 37,504 ± 6,240
25 43,462 ±6,230
50 43,197 ±5,823
aGroup I and control medium data represent mean cpm ± SEM 
for three day 9-10 HCCM samples and three CM samples, 
respectively, each tested on three PBL populations (total 
n=9) . Group II and III values are the mean cpm ± SEM from 
three day 15-16 HCCM samples and three day 25-26 HCCM 
samples, respectively, each tested on four PBL populations 
(n=12). HCCM from all Groups (I,II and III) added at 25% 
and 50% of well volume suppressed lymphocyte prolferation 
(P<.001) in mitogen-stimulated cultures, but CM did not 
(P>. 05) .
Supplemented to cultures at 1 i^g/well.
Supplemented to cultures at 5 |lg/well.
*Significant lymphocyte suppression relative to stimulated 
controls (Pc.001).
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HCCM Characterization. After treatment (HP, FT, NCF), the 
addition of increasing volumes of HCCM suppressed (P<.05) PWM-induced 
lymphocyte proliferation in a dose-dependent manner (Table 3). 
Similarly treated CM did not suppress (P>.05) proliferation (data not 
shown). There was no difference in overall suppressive activity 
(determined as % of stimulated control) of HCCM between treatments, 
nor did suppressive activity of treated samples differ (P>.05) from 
that of non-treated (FF) HCCM (Fig. 3).
The fractions of HCCM separated by 10,000 and 30,000 MW 
exclusion amicon microconcentrators suppressed (Pc.Ol) lymphocyte 
proliferation with the larger MW HCCM fraction significantly more 
suppressive (P<.01) than the smaller MW fraction (Figs. 4 and 5). The 
addition of 8 Jil/well of HCCM filtrate and retentate fractions 
decreased the percent stimulation to 71.3 -± 5.0 (mean i SEM) and 21.4 
±1.7 respectively (10,000 MW exclusion centricon), and 77.2 ■£ 5.1 and 
28.4 ± 9.1 respectively (30,000 MW exclusion centricon), while the
addition of either MW fractions of CM had no suppressive effect on
percent lymphocyte proliferation (103.6 ± 5.1 and 118 7.1 (10,000 MW
centricon) and 112.3 ± 1.0 and 108.5 ± 7.3 (30,000 MW centricon)).
Interspecies Assay. The addition of HCCM to goat, donkey and 
horse FWM-stimulated lymphocytes decreased (P<.05) lymphocyte
proliferation across all species (Fig. 6). Overall suppression
(determined relative to stimulated controls) was less in goat 
lymphocyte cultures than that in horse or donkey cultures (P<.05), but 
there was no difference between percent suppression of donkey and 
horse cultures. Polynomial regression analysis used to describe the 
dose response suppression curves resulting from the addition of HCCM
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TABLE 3. Effect of treated HCCM on PWM-stimulated 
horse PBL proliferation.3
JRgfiM Treatment
HCCM added
lUl/welJ.)
Fresh-
Frozen
0.0
0.75
1.56
3.125
6.25
12.5
25.0
70,483 ± 3,844 
36,370 ± 473 
20,959 ± 1,504 
15,075 ± 1,076 
8,986 ± 881 
5,107 ± 457 
3,056 ± 248
Frozen-
Thawed
73,645 ± 5,156 
30,281 ± 684 
21,098 ± 1,587 
13,400 ± 1,286 
11,707 ± 1,007 
5,178 ± 556 
3,184 ± 283
Heat-
Treated
Nitrocellulose 
 Filtered
77,985 ± 4,719 
33,363 ± 1,439 
21,790 ± 1,910 
9,627 ± 1,817 
5,382 ± 1,641 
2,904 ± 362 
1,527 ± 122
Non- stimulate d
14,579 — 2,208 12,843 ± 3,122 13,998 ± 3,402
39,048 ± 9,774 
21,662 ± 5,735
14,645 — 4,427 
8,078 ± 2,787 
4,424 ± 1,914 
2,463 ± 1,097 
1,434 ± 580
2,951 ± 1,316
aData represent mean cpm i SEM (n=3). All samples expressed 
suppressive activity (P<.05) relative to stimulated controls 
(0.0 l^l/well) .
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Figure 3 . Suppressive activity of treated (heat-treated 90^ for 30 
min (HT), filtered 2x through a .2 Jim nitrocellulose filter (NCF), 
frozen to 80°C and thawed to roan temperature 8x (FT)) vs non-treated 
fresh-frozen (FF) HCCM on FWM-stimulated PBL proliferation. Columns 
represent mean % of control + SEM (n=3) with the addition of 
increasing quantities of HCCM. All saitples expressed suppressive 
activity (P<.05), and there was no difference (P>.05) between the 
activity of treated and non-treated HCCM.
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Figure 4. Effect of >10,000 MW and <10,000 MW fractions of 
HCCM and CM on PWM-stimulated PBL. Fractions were separated 
by amicon microconcentrator centrifugation. Values 
represent mean % of stimulated control i SEM (n=3) . Both 
HCCM fractions were suppressive compared to CM fractions 
(P<.05). Different superscripts denote significantly 
different suppressive activity (P<.05).
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Figure 5. Effect of >30,000 MW and <30,000 MW fractions of 
HCCM and CM on PWM-stimulated PBL. Fractions were separated 
by amicon microconcentrator centrifugation. Values 
represent mean % of stimulated control — SEM (n=3) . Both 
HCCM fractions were significantly suppressive (P<.05) 
compared to CM fractions. Different superscripts denote 
significantly different suppressive activity (P<.05).
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Equations:
Goat y = 79.8 - 5.9x 
Donkey y = 75.1 - 12x + .56x2 
Horse y -  68.8 - 15.7x + .72x2
Donkeyb 
Goatc 
Horse b
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Figure 6. Effect of HCCM on FVM-stirnulated PBL of horses, donkeys 
and goats. Values are mean % of stimulated control ± SEM (n=3) of PEL 
with the addition of increasing quantities of HCCM. Overall 
suppression of goat PBL was less (P<.05) than that of horse or donkey 
PBL. There was no difference (P>.05) between horse and donkey PBL 
suppression. The goat suppressor curve follows a linear regression 
equation while the donkey and horse curves follow quadratic equations 
with the same slope (ANOR; r2=.88).
a% stimulated control = average cpm experimental/average cpm 
stimulated control x 100. Average cpm for goat, donkey and horse 
stimulated controls were 122,542, 78,199 and 46,036 respectively.
b'different superscripts denote significant differences in overall 
suppression caused by HCCM supplementation (P<.05).
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to lymphocyte cultures of the three species determined that the curves 
representing horse and donkey lymphocyte suppression had the same 
slope and were best fit by a quadratic equation while the goat's best 
fit a linear equation.
DISCUSSION
The data presented herein indicate that the preirrplantation 
horse conceptus produces a factor that suppresses in vitro mitogen- 
induced horse lyirphocyte proliferation. This suppression is not 
mediated through cytotoxicity. The substance responsible for 
suppressive activity is released by the embryo as early as day 9-10 of 
development and continues to be produced at least through day 26 of 
gestation. All horse embryos collected at day 9-10 had hatched from 
their zonae pellucidae and were surrounded by the equine embryonic 
capsule. Whether or not these embryos produce a suppressor substance 
prior to hatching from their zonae was not determined. It is possible 
that the embryo, while surrounded by the fairly non-antigenic zona, is 
not in danger of immunological attack and thus may not produce a 
suppressor factor. It has been reported that bovine conceptus-derived 
suppressor activity is non-detectable prior to day 10, variable from 
day 10-12 and only definitely present by day 14 (Cray et al., 1988). 
Such reports indicate that, at least in cattle, suppressor substances 
are not produced and/or release! by the embryo prior to zona hatching. 
It is possible however, that suppressor factors are produced early but 
in such small levels that they are not detected by the in vitro 
biological assay used to evaluate suppression. Suppressive activity of 
HCCM varied between, but was definitely present in, the three day 9-10 
cultures. The HCCM with the greatest suppressive activity was that
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from cultures in which embryos remained fully expanded and grew in 
size during the 24 h culture period. This observation may .indicate 
that the production of the suppressor factor correlates either with 
the health of the embryo or simply with an increased number of cells 
capable of producing the substance. It has been proposed that the 
measure of embryo-derived irrmunoregulatory function could be used in 
predicting the viability of embryos prior to their transfer to 
recipients. However, in the cow such an assay would not be practical 
since suppressor activity of embryos is not detected until after day 
10, and embryo transfer in cattle is carried out between days 6 and 8. 
The transfer of embryos at day 9 in the horse is successful, and since 
equine embryos seem to express immunosuppressive activity at this 
stage of development, it is possible that a measurement of this 
function could be useful in predicting post transfer embryo survival. 
To do so, a quicker more sensitive assay than lymphocyte proliferation 
would be required. The difference in suppressive activity of HCCM from 
Group I vs. Group II and III is likely simply due to the difference in 
the tissue:medium ratio in the cultures, resulting in a lower 
concentration of the day 9-10 embryo-derived factors.
Because production of the suppressor factor begins as early as 
day 9 and continues through day 26, it is not likely that this 
substance is responsible for maternal recognition of pregnancy, which 
occurs between day 13 and 15 (Hershman and Douglas, 1979). Such
proteins in other species are produced mainly during the specific 
window when maternal recognition occurs (Davis and OTT, 1989; Godkin 
et al., 1989). However, we can not rule out the possibility that the 
substance plays a role in the event.
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Lymphocyte proliferation induced by any of the three different 
mitogens was suppressed by the addition of HCCM indicating that the
suppressor factor is non-antigen specific. Furthermore, the use of Con
A and PHA (T-lynphocyte stimulators) and FWM (a T and B-lymphocyte 
stimulator) indicates the suppressor factor might affect both 
lymphocyte subsets. However, because FWM is a T-cell dependent B-cell 
stimulator, it is possible that FWM B-cell stimulation is suppressed 
indirectly ty suppression of T-cells which results in decreased 
lyrtphokine production (Sharon, 1983; Weiss, 1989). The fact that 
lymphocyte proliferation was not affected ty the addition of CM to the
lymphocyte cultures ensures the suppression observed with HCCM is not
an artifact resulting from the use of certain flasks or incubation 
regimens. Lymphocyte suppression resulting from the incubation of 
medium in certain flasks or plates has been reported previously (Crcy 
et al., 1988).
The immunosuppressive effect of progesterone and other steroid 
hormones is well documented, tut the level of hormone required to 
suppress lymphocyte proliferation in vitro exceeds physiological 
levels. As much as 5 |xg/ml is required in order to achieve suppression 
of PHA and Con A stimulated lymphocyte proliferation (Mori et al., 
1977; Siiteri and Stites, 1982). Only picogram to nanogram 
concentrations of hormones are found in equine blastocoelic fluid or 
in equine conceptus culture medium (Flood et al., 1979; Marsan et al., 
1987) indicating that, even localized around the conceptus, the 
hormone levels produced would be far below that required for 
suppressing lymphocyte proliferation. However, to ensure that the 
suppression we observed was not hormone-induced, HCCM was run through
69
the amicon microconcentrators with MW exclusions of 10,000 and 30,000. 
Since the suppressor substance was found to be >30,000 MW we can 
conclude that it is not a steroid hormone. The fact that the <30,000 
and <10,000 fractions were slightly suppressive might indicate the 
presence of hormones and/or interferons in those smaller MW fractions.
HCCM was subjected to harsh treatments of freeze-thawing and 
heating at 90°C for 30 min in an attempt to denature the proteins in 
the sample. Because no loss of biological activity of the HCCM 
suppressor factor was observed after treatments, it is possible the 
substance is not a protein. Alternatively, it may be a protein with a 
very stabile structure perhaps due to many disulfide bridges. It is 
also possible the substance does undergo structural denaturation tut 
the active sites remain intact or reanneal after treatment. Although 
the treatments had no effect on the activity of the suppressor 
substance, and the substance was not removed from HCCM when filtered 
through nitrocellulose which binds proteins through hydrophobic 
interactions, we have not yet ruled out the possibility the suppressor 
factor is a protein. The stability of its biological activity and the 
fact that the HCCM suppressor factor is >30,000 MW serve as evidence 
that this horse suppressor substance is different from the proteins 
that exhibit antiviral activity and that are responsible for maternal 
recognition of pregnancy in sheep and cows. Both oTP-1 and bTP-1 are 
of the alpha-interferon family (Imakawa et al., 1987; Stewart et al., 
1987; Charpigry et al., 1988) and like other alpha-interferons, are 
<30,000 MW and unstable when treated with heat or repeated freeze- 
thawing. A porcine conceptus-derived interferon-like protein with 
anti-viral activity has also been identified, and it too is small
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(22,000-24,000 Mr) and extremely labile (Cross and Roberts, 1989). We 
therefore conclude that the suppressor factor described herein is most 
likely not of the interferon family.
We have suggested that if the conceptus-derived suppressor 
substance plays a significant role in protecting the conceptus from 
maternal immunological assault, the inability of it to cross-react 
with lynphocytes of another species could in part explain the failure 
of interspecies pregnancies. It has been shown with sheep and goats 
that medium conditioned by 20-day old conceptuses exhibited greater 
suppressive activity when added to lynphocytes of the same species as 
compared to that seen when added to lynphocytes inter specifically 
(Roth and White, 1989). The lack of immunosuppressive capacity of 
conceptus-derived products of one species in the maternal environment 
of another species could explain the repeated failure of sheep/goat 
interspecies pregnancies and the apparent evidence of inmunological 
rejection of the conceptus.
Horses and donkeys provide a unique model for the study of 
interspecies cross-reactivity of conceptus-derived substances because 
both interspecies and hybrid pregnancies are successful. We show 
herein that there is no difference in overall suppressive activity of 
HCCM when added to donkey lynphocytes as compared to horse 
lymphocytes. Thus, it is possible that the horse conceptus-derived 
suppressor factor does efficiently cross-react with donkey lynphocytes 
and this may explain, in part, how donkeys are able to carry horse 
fetuses to term. When added to goat lynphocytes, however, HCCM is much 
less suppressive indicating that with more distantly related species 
the HCCM suppressor factor is not as efficient at inhibiting
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lymphocyte proliferative responses. Furthermore, both donkey and horse 
lymphocyte suppressor curves followed quadratic functions with the 
same slope indicating that the mechanism of action of the suppressor 
substance in HCCM is similar on lynphocytes of the two species. With 
the much less-related caprine species, the HCCM suppressor substance 
appears to be acting in a different manner resulting in a suppressor 
curve that follows a linear function. Although it is suppressive, HCCM 
is much less suppressive when added to lynphocytes of the caprine 
species, and also appears to foe suppressing the lynphocytes through a 
much less effective mechanism. Although these data provide evidence 
for species-specific activity of HCCM, we cannot ignore the 
possibility that goat lynphocytes may be inherently more difficult to 
suppress than equine lynphocytes when stimulated with FWM.
In summary, we have found that from day 9 through day 26 of 
development the equine conceptus produces an irmtunosuppressive factor 
that inhibits in vitro horse lymphocyte proliferation in a non-antigen 
specific manner. The suppressor factor appears to be >30,000 MW and 
maintains full biological activity after repeated freeze-thaw and 
after heating to 90°C for 30 minutes. This substance exhibits its 
suppressive effect in a similar manner on donkey and horse 
lymphocytes, yet on lymphocytes of the less-related goat species, 
suppressive activity is significantly decreased. These data indicate 
that the substance is, to seme degree, species-specific. Determining 
the significance of this immunoregulatory substance in maintaining the 
conceptus, and its possible relationship to successful interspecies 
pregnancies should help in our understanding of the puzzling 
phenomenon of fetal allograft survival.
CHAPTER IV
PGE2-INDEPENDENT IMMUNOSUPPRESSIVE ACTIVITY OF 
HORSE TROPHOBLAST TISSUE3
INTRODUCTION
Suppression of the maternal immune response at the fetal- 
maternal interface may be imperative for the survival of the 
allogeneic conceptus during pregnancy. Irrmunosuppressive factors 
associated with placental and/or uterine tissues and their secretions 
have been reported for several species, including mice (Clark et al., 
1985,1986; Chaouat, 1987), humans (Daya and Clark, 1986; Pockley et 
al., 1988), sheep (Segerson et al., 1984; Hansen et al., 1987; Murray 
et al., 1987; Roth et al., 1991), goats (Roth et al., 1991), pigs 
(Murray et al., 1978), cows (Roberts, 1977; Segerson and Gunsett, 
1990; Segerson and Libty, 1990) and horses (Roth et al., 1990). In 
addition, immune cells with suppressor activity accumulate in and 
around the placenta (Slapsys and Clark, 1982,1983; Clark et al., 1983; 
Brierley and Clark, 1985; Uren and Boyle, 1990). Both placental 
suppressor cells and decidual cells, produce the immunosuppressive 
prostaglandin, FGE2 (S codr as et al., 1990). Likewise, early 
developing embryos of several species produce FGE2 (Lacroix and Kann, 
1982; Pakrasi and Dey, 1982; Hwang et al., 1988; Holmes et al., 1990). 
PGE2 suppresses IL-2 production by T lynphocytes (Rappaport and Dodge, 
1982; Walker et al., 1983) and induces T suppressor cells (Chouaib and 
Fradelizi, 1982; Delfraissy et al., 1982; Kaszubowski and Goodwin, 
1982). Therefore, it has been suggested that PGE2 is an important 
immunosuppressant of pregnancy. The fact that PGE2 from decidual cells
3 Roth, T.L., K.L. White, D.L. Thompson, Jr. and D.W. Horohov. J. Reprod. fcnunol.
(In review).
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and decidual macrophages inactivates T lymphocytes (Parhar et al.,
1989) and natural killer (NK) cells in the decidua, (Scodras et al.,
1990) supports the theory that PGE2 activity is conducive to fetal 
survival (Lala et al., 1990).
We reported that horse conceptus-conditioned medium suppresses 
in vitro lymphocyte proliferation in vitro (Roth et al., 1990). The 
specific objective of this study was to determine if indomethacin, a 
prostaglandin inhibitor, could reduce horse trophoblast-derived 
immunosuppressive activity.
MATERIALS AND METHODS
Animals and conceptus collections. Conceptuses were 
obtained from mares on day 21 of gestation according to procedures 
described in Chapter III. The flushing medium consisted of sterile 
PBS supplemented with 1% penicillin/streptomycin (Gibco, Grand Island, 
NY).
Conceptus cultures. Three conceptuses, each from a different 
mare, were obtained on day 21 of gestation. Under sterile conditions, 
conceptuses were rinsed twice with PBS. Both the embryonic capsule 
and the fetus proper were removed from the trophoblast tissue of each 
conceptus. The trophoblast tissue was cut into two approximately 
equal sections and each section was rinsed twice in sterile RFMI-1640 
medium supplemented with 1% antibiotic/antiirycotic (RFMI). Each 
trophoblast section from each conceptus was randomly assigned to 2 
treatments. For treatment 1, each tissue section was placed in a 
tissue culture flask (25 cm2) containing 5 ml RFMI. Treatment 2 
tissue sections were each placed in a flask with 5 ml RFMI containing 
1 x 10-4 M indomethacin (Sigma, St. Louis, MD). An additional flask
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was set up with 5 ml indomethacin control medium (I-CM) which 
consisted of RFMI with 1 x 10-4 M indome thacin but no trophoblast 
tissue. A total of 6 trophoblast tissue cultures (3 in RFMI and 3 in 
RIMI + indome thacin) and a seventh flask containing I-CM were
incubated for 28 h at 37°C in a humidified atmosphere of 5% CO2 and
air. Following incubation, horse trophoblast-conditioned medium 
(HTCM) and indomethacin-treated trophoblast-conditioned medium (I- 
HTCM) were obtained by first pouring the contents of each flask into a 
conical tube and then centrifuging the tubes at 1,500 x g for 10 min. 
Supernatants were filtered through a .2 pm filter and were stored in 1 
ml aliquots at -80°C. Following centrifugation, the tissue volume in 
each culture was determined. The volume was consistent, measuring 
approximately 100 pi of tissue in each culture. I-CM was similarly 
aliquoted and stored at -80°C.
Lymphocyte proliferation assay. Peripheral blood
lynphocytes were obtained as described in chapter III. Cultures were 
carried out in quadruplicate in 96-well, round-bottomed tissue 
culture-treated plates. Non-stimulated control cultures contained 25 
pi cell suspension (1 x 105 cells) and 75 pi EFMI+. Stimulated
control wells received 25 pi cells, 25 pi RFMI+ containing 0.1 pg
pokeweed mitogen (PWM) and 50 pi RFMI+. Treated cultures received 25 
pi cells, 25 pi RFME+ with 0.1 pg EVM and 2.5, 5 or 10 pi of HTCM 
(n=3), I-HTCM (n=3) or I-CM (n=l) diluted in 50 pi RFME+. All 
cultures were carried out simultaneously with the same 3 PBL 
populations and the final volume of each well was 100 pi. Cultures 
were maintained in an incubator at 37°C in a humidified atmosphere of 
5% CO2 and air. 3H-thymidine was added to the culture (lpci/well) 99 h
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after the start of culture and cells were harvested 15 h later. 
Radioactivity on glass fiber filters was determined fcy liquid 
scintillation counting.
Radioimmunoassay. The radioimmunoassay (RIA) used to 
quantify PGE2 in each HTCM and I-HTCM sample was conducted according 
to published procedures (Hwang et al., 1975; Hwang, 1985). ^h-pge2 
(100-200 Ci/mmol) used in the RIA was obtained from DuPont NEN 
Research Products (Boston, MA). An aliquot of HTCM from one conceptus 
was divided into two fractions using a 30,000 MW cut-off 
microconcentrator. The retentate fraction (>30,000 MW) was diluted 
back to its original volume with RFMI and the concentration of PGE2 
was determined. A sample of RFMI served as a control for any 
background interference that might be associated with the culture 
medium.
Statistical Analysis. Average cpm for quadruplicate wells of 
the lymphocyte proliferation assay were calculated and the results 
analyzed by AN3VA using the general linear model procedures of the SAS 
computer package (Luginbuhl et al., 1985). To determine 
immunosuppressive activity, lymphocyte proliferation in I-CM, HTCM and 
I-HTCM treated cultures was compared to that in stimulated control 
cultures using Tukey's mean comparison tests. Similarly, Tukey's mean 
comparison tests were used to determine within treatment differences 
between the addition of 2.5, 5 and 10 (ll/well of I-CM, HTCM and I- 
HTCM.
RESULTS
Lymphocyte proliferation assay. The results of the 
lymphocyte proliferation assay are shown in Fig. 7. Each data point
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Figure 7. The effect of indomethacin control medium (I-CM), 
horse trophoblast-conditioned medium (HTCM) and 
indomethacin-treated HTCM (I-HTCM) on PWM-stimulated horse 
PBL proliferation. Different superscripts designate 
differences in lymphocyte proliferation (P<.01). Stimulated 
control values (150,000 ± 25,000 cpm; mean ± SEM) did not 
differ (P>.05) from those of I-CM-treated cultures. 
Lymphocyte proliferation was less (Pc.01) in both HTCM and 
I-HTCM treated cultures as compared to that in stimulated 
controls.
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represents the mean ± SEM (cpm) for three lymphocyte populations 
treated with I-CM (n=l), HTCM (n=3) and I-HTCM (n=3). FWM-stimulated 
lymphocyte proliferation in HTCM and I-HTCM treated cultures was less 
(Pc.Ol) than that in I-CM-treated or stimulated control cultures. 
Proliferation in I-CM-treated cultures did not differ (P>.05) from 
that in stimulated control cultures. Immunosuppressive activity of 
HTCM and I-HTCM did not differ (P>.05). Results of the within 
treatment comparisons indicated no differences (P>.05) in 
proliferation with the different quantities of HTCM and I-CM. 
However, the addition of 10 *11 of I-HTCM suppressed lynphocytes more 
(P<.05) than the addition of 2.5 *ll I-HTCM.
Radioimmunoassay. The concentration of PGE2 in each sample of 
HTCM and I-HTCM, as determined fcy the FGE2 RIA, are shown in Table 4. 
The effectiveness of indome thacin, as a PGE2 inhibitor in the 
trophoblast cultures, was determined fcy comparing the concentration of 
PGE2 in I-HTCM to that in HTCM for each trophoblast sample. Addition 
of indcmethacin to horse trophoblast cultures reduced PGE2 production 
fcy 91 ± 1.6%. Not shown in Table 4 are the data for the >30,000 MW 
fraction of HTCM (Tissue sample 1) which was 38 pg/ml PGE2.
DISCUSSION
The results of this study indicate that PGE2 is not the primary 
factor responsible for horse trophoblast-derived immunosuppressive 
activity. Our results differ from what has been reported for decidual 
type placentae of humans and mice where PGE2 appears to play a 
critical role in the suppression of immune cells at the fetal-maternal 
interface.
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TABLE 4. PGE2 concentrations (ng/ml) in horse 
trophoblast-conditioned medium (HTCM) and 
indomethacin-treated HTCM (I-HTCM)a .
Trophoblast
tissue sampleb  HTCM
1 18.56
2 4.46
3 15.02
I-HTCM
1.33
.50
1.42
% Decrease0
93
89
91
Mean ± SEM 12.68 ± 7.4 1.08 ± .53 91 ± 1.6
aThe RPMI control value was 0.00 pg/ml.
trophoblast was obtained from day 21 horse conceptuses. 
Tissue sections from each trophoblast sample were cultured 
in RPMI and RPMI + indomethacin to generate HTCM and I-HTCM, 
respectively.
the inhibitory effect of indomethacin on PGE2 production 
was calculated using the equation (1 - I-HTCM/HTCM x 100).
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In the murine species, decidua contain T lynphocytes of several 
subsets (Kearns and Lala, 1985) as well as natural killer cells 
(Scodras et al., 1985). Excessive NK cell infiltration into the feto­
placental unit appears to be responsible for spontaneous abortion of 
specific murine pregnancies (Gendron and Baines, 1988). During 
successful murine pregnancies, suppressor cells in the decidua and 
decidual cells themselves, inactivate NK cells (Crcy et al., 1985; 
Gambel et al., 1985; Scodras et al., 1990). Recently, it has been 
shown that NK cell suppression is mediated fcy PGE2, and the addition 
of indomethacin (10-5 M) or anti-PGE2 antibody revives NK activity in 
the decidua (Scodras et al., 1990). Additional in vivo evidence 
concerning the significance of PGE2 in maintaining pregnancy was 
provided fcy Lala et al. (1990), who demonstrated that chronic 
administration of indomethacin to pregnant mice causes abortion and 
embryo resorption.
Similar to murine placentae, first trimester human placentae 
contain decidual cells and decidual macrophages that secrete PGE2 
which, in turn, inhibits T lymphocyte activity fcy blocking expression 
of the interleukin-2 receptor and inhibiting the production of 
interleukin-2 (Lala et al., 1988). However, in agreement with our 
findings, Uren and Beyle (1990) demonstrated that suppressive activity 
of human placental macrophages was not inhibited fcy indomethacin. 
Additionally, Scodras et al. (1990) found that the concentration of 
PGE2 in murine decidual cell supernatants following 20-hr in vitro 
culture was much lower than that required for NK cell suppression 
induced fcy decidual cells. The authors suggested that, in addition to 
FGE2, decidual cells produce other suppressor molecules. Our data
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support this theory. While indomethacin effectively decreased PGE2 
production, immunosuppressive activity of HTCM and I-HTCM did not 
differ, thus it appears there are factors other than PGE2 responsible 
for the immunosuppressive activity in HTCM. These results are not 
surprising in view of the fact that conceptus-derived soluble 
suppressor proteins have been identified in a number of species (Clark 
et al., 1986; Daya et al., 1986; Murray et al., 1987).
There are three additional pieces of evidence supporting our 
conclusion that PGE2 is not responsible for HTCM-induced 
immunosuppression. First, PGE2 is capable of inhibiting 3H-thymidine 
incorporation fcy mitogen-stimulated lymphocytes at concentrations of 
10-8 M, but to attain at least 65% suppression, a concentration of 10-7 
M is required (Goodwin et al., 1977). In this study, we achieved 65% 
suppression of lymphocyte proliferation with PGE2 concentrations in 
the lymphocyte culture wells ranging from 10-9 to 10-11 m. 
Furthermore, it has been reported that PGE2 does not inhibit FWM- 
stimulated peripheral blood lymphocytes (Goodwin et al., 1977). Yet, 
in this study and in previous work (Roth et al., 1990), we have 
demonstrated potent suppression of FWM-stimulated horse PBLs with 
horse conceptus - condi t ioned medium. Finally, we previously reported 
that following amicon microconcentrator centrifugation, the 
immunosuppressive activity of horse conceptus-conditioned medium is 
contained in the >30,000 MW retentate fraction (Roth et al., 1990). 
While in that report we mentioned the apparent lack of hormone or 
prostaglandin contribution to the suppressive activity, we could not 
rule out the possibility that these substances retained in the >30,000 
MW fraction. In this study, we determined that a single passage
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through the microconcentrator reduced the PGE2 concentration of the 
retentate fraction fcy 99.7% relative to that of the whole sample.
Together, data from previous work indicating the large size of 
the horse conceptus-derived suppressor factor(s) (Roth et al., 1990) 
and from this study in which the inhibition of prostaglandin 
production did not affect suppressor activity of cultured horse 
trophoblast, indicate that PGE2 is not the primary immunosuppressant 
produced fcy the pre-irrplantation horse conceptus.
CHAPTER V
HORSE CONCEPTUS-DERIVED SUPPRESSION OF 
T AND B LYMPHOCYTE PROLIFERATION!INTERLEUKIN-2 
RECEPTOR INVOLVEMENT4 
INTRODUCTION
The immunosuppressive activity of a >30,000 molecular weight 
(MW) factor present in horse conceptus conditioned medium (HCCM) has 
previously been reported (Roth et al., 1990). Results from subsequent 
work have shown this suppressor factor (HCCM-SF) to be >100,000 MW. 
High molecular weight components of conceptus cultures and/or gravid 
uterine fluid of other domestic species, including the cow (Segerson 
and Bazer, 1989), sheep (Hansen et al., 1987; Murray et al., 1987) and 
pig (Murray et al., 1987), also suppress lynphocytes when supplemented 
to in vitro blastogenesis cultures. It has repeatedly been suggested 
that these suppressive factors play a role in protecting the conceptus 
from maternal irrmunological attack during pregnancy. In the horse, one 
such role may be to temporarily protect the endometrial cups which, 
although surrounded by lynphocytes, are not destroyed until day 120 of 
pregnancy (Allen, 1979). Thus far, most investigations have been 
primarily directed towards identifying and characterizing uterine and 
conceptus-derived factors (Murray et al., 1978; Godkin et al., 1982; 
Hansen et al, 1987; Newton et al., 1988; McDowell et al., 1990) while 
their functional significance remains largely unknown.
Seme information pertaining to the immunosuppressive mechanisms 
of components obtained from uterine fluid or conceptus tissue has been
4 Roth, T.L., K.L. White, D.L. Thcrpson, Jr., S. Rahmanian and D.W. Ifordhov. J. 
Reprod. Fertil. (In review).
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reported for humans (Pockley and Bolton, 1990; Saito et al., 1990), 
mice (Clark et al., 1985; Mayumi et al., 1985; Clark et al., 1986), 
sheep (Segerson, 1988) and, more recently, cows (Segerson and Libfcy,
1990). In these studies, suppressor activity was identified in 
lymphocyte cultures as decreased ^H-tbymidine uptake fcy cells 
following mitogen stimulation. There are mitogens available that 
stimulate B and/or T lynphocytes preferentially (Sharon, 1983), but in 
most immunosuppressive studies only PHA, a potent T cell activator, 
has been used to stimulate lymphocyte proliferation. Because cell- 
mediated and not humoral immunity is of greater concern in fetal 
allograft acceptance, T cells have been the focus of most attenpts to 
elucidate suppressor factor mechanisms.
Production of IL-2 and the expression of the high affinity IL-2R 
are critical for proliferation of T cells in response to either PHA or 
antigen (Depper et al., 1984). The IL-2R has been identified and 
described as a dimer consisting of a p55 alpha chain with low affinity 
for IL-2 and a p75 beta chain with slightly greater IL-2 affinity 
(Greene et al., 1986; Tsudo et al., 1986; Teshigawara et al., 1987; 
Smith, 1988). With mitogenic or allogeneic stimulation, the two chains 
are expressed together on the cell surface to form the high affinity 
IL-2R conplex which, when bound to IL-2, is largely responsible for 
signaling cell proliferation (Sharon et al., 1986; Smith, 1988). 
Recombinant human IL-2 (rIL-2) will interact with the IL-2R of many 
species, including the horse (Fenwick et al., 1988). An antibod/ to 
the IL-2R (anti-Tac) blocks IL-2 binding (Robb et al., 1981; Leonard 
et al., 1982; Sharon et al., 1986), inhibits cell proliferation (Robb 
et al., 1981) and may even prevent allograft rejection (Kirkman et
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al., 1985). Data have suggested that uterine/conceptus suppressor 
factors act similarly, disrupting the IL-2/IL-2R interaction to 
inhibit blastogenesis. A soluble suppressor factor obtained from mouse 
decidua blocks the response of T cells to IL-2 by interfering with IL- 
2R (Clark et al., 1985; Clark et al., 1986). Pregnancy zone protein 
reduces IL-2 production but not IL-2R expression (Saito et al., 1990). 
Human placental supernatant inhibits both IL-2 and IL-4 driven 
proliferation of CTLL-2 cells (Menu and Chaouat, 1989), an IL-2
dependent murine cell line (Gillis et al., 1978). Suppressive activity 
of substances found in uterine luminal fluid of pregnant sheep and 
cows may also be mediated through alterations of the IL-2 system. In 
both species, uterine fluid suppressor factors block IL-2 mediated 
blastogenesis of T cells (Segerson, 1988; Segerson and Gunsett, 1990), 
and it has been suggested that bovine uterine luminal proteins act by 
blocking IL-2R recognition in addition to binding directly to IL-2 
(Segerson and Libby, 1990).
While mitogen-stimulated lymphocyte proliferation assays have 
provided valuable information about the in vitro response of these 
cells to immunosuppressive factors, the response of specific cell 
subsets has not been determined. Antibodies to unique cell subset 
antigens (CD4, CD5 and CD8) are available for labeling specific cell 
populations. Human T cells express many cell surface molecules such as 
the CD5 molecule which is present on virtually all T cells (Hedrick et 
al., 1984). The T cell population can be divided into two broad
subsets, T helper and T suppressor/cytotoxic cells, by their 
expression of CD4 and CD8 antigens, respectively (Sprent, 1989). 
Similarly, there exist antibodies to equine lymphocytes that bind
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either the entire T cell population or a T suppressor cell subset 
(Wyatt et al., 1988). Specific fluorescent antibody labeling followed 
by fluorescence activated cell sorter (FACS) analysis provides an 
accurate method for iirmunopheno typical ly distinguishing and 
quantifying cell subsets in a mixed cell population (Jackson and 
Warner, 1986).
The experiments described herein were designed 1) to examine 
the affect of HCCM-SF on B and T lymphocytes using various mitogens 
and FACS analysis 2) to determine the temporal relationship of HCCM- 
SF activity and lyitphocyte activation and 3) to better define the 
proposed IL-2 associated mechanism of lymphocyte suppression. The 
results of these experiments may increase our understanding of the 
fetal-maternal immunological interaction in utero.
MATERIALS AND METHODS
Animals and Concept us Cultures. The horse breeding regimen 
and conceptus collection techniques were carried out as described in 
Chapter III. Conceptuses were collected fcy non-surgical uterine 
flushing on Day 20 (ovulation = Day 0) using sterile PBS supplemented 
either with 1% calf serum and 1% antibiotic/antimycotic (Group I), or 
with only 1% antibiotic/antirrycotic (Group II). Under sterile 
conditions, conceptuses were rinsed twice in their respective medium, 
after which Group I conceptuses were rinsed once in RIMI+, and Group 
II conceptuses were rinsed in RTMI-1640 with 1% antibiotic/antiirycotic 
(RfMI). The three Group I conceptuses were each placed in a 50-ml 
tissue culture flask containing 20 ml REMI+. Cultures were incubated 
for 48 h at 37°C in a humidified atmosphere of 5% CO2 and air. The 
three Group II conceptuses were each placed in a 50-ml tissue culture
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flask containing 15 ml REMI and were incubated for 30 h under the same 
conditions described for Group I. Within both Group I and Group II, 
conceptus culture supernatants (HCCM I and HCCM II, respectively) were 
pooled. Both pooled samples were centrifuged (600 x g; 20 min), 
filtered (.2 Jim) and stored in aliquots at -80°C. A lymphocyte 
proliferation assay was used to determine that there was no difference 
(p>.05) in suppressive activity between HCCM I and HCCM II (Table 5). 
Control medium (CM) consisted of REMI or REMI+ incubated and stored 
similarly.
For sane experiments, HCCM and CM samples were both fractionated 
by molecular weight using microconcentrator centrifugation. Two 
microconcentrators with 100,000 MW exclusion membranes were rinsed 
with 500 |ll of REMI-1640 (850 x g; 50 min). After rinsing, 500 |il of 
CM and HCCM were each pipetted into one of the microconcentrators. 
Samples were centrifuged (850 x g; 40 min) and flow-through fractions 
(<100,000 MW) were collected. Retentate fractions were resuspended in 
500 |jll REMI-1640 and, again, centrifuged. Flow-through volumes were 
discarded. Retentate was resuspended to 500 |il, the centricons were 
inverted and the retentate fractions (>100,000) were collected off the 
filter membranes into the collection cups by centrifugation (600 x g; 
5 min). Both fractions of CM and HCCM were filtered (.2 pm) and 
diluted to 600 pl/ml in RFMI+.
Lymphocyte Proliferation Assays. Unless otherwise stated, 
the lymphocyte proliferation assays were carried out as follows. 
Lymphocytes were obtained according to procedures described in Chapter 
III. Cultures were prepared in quadruplicate for each PEL population 
in 96-well round-bottomed tissue culture-treated plates and each well
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TABLE 5. The effect of HCCM I and HCCM II on PWM- 
stimulated lymphocytes.a
Volume added HCCM II
(Jll/well)
0 (control) 44 ± 8b 41 ± 7b
1 36 ± 4c 32 ± 4c
5 22 ± 3cd 20 ± icd
10 15 ± 26 12 ± le
aValues represent mean cpm -±- SEM (x 10“3) for three 
lymphocyte populations.
bcdepifferent superscripts designate differences (p<.05; 
Tukey mean comparisons).
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received 1 x 10^  cells (25 Jil). EWM, diluted in REMI-1640, was added 
to stimulate cell proliferation (. 1 |xl PWM/well). HCCM or fractionated 
HCCM was added in concentrations specified for each assay, and final 
well volume was 100 |ll. The assays were completed as described in 
Chapter III.
Preliminary Assay. To determine the concentrations of PHA 
required to induce optimal and sub-optimal proliferative responses in 
our lymphocyte assay, three.populations of PBLs were tested with 
serial dilutions of PHA (3 to .0625 jil/well). Maximal cell 
proliferation was achieved using 1 (ll/well while a suboptimal response 
(approximately 50% of maximum) resulted from the use of .125 jil/well 
(Fig. 8).
Mitogen Comparison Assay. The suppressive activity of HCCM 
II on LPS-, PHA- and FWM-stimulated lymphocytes was compared. HCCM II 
was serially diluted in RFMI+ such that treated wells contained HCCM 
II at 20 to 1.25 % of total volume while control wells received only 
RTMI+. FWM (4 (ig/ml), PHA (5 ill/ml) and LPS (.4 Jig/ml) were added to 
wells in 25 (ll volumes. In our lab, these concentrations of LPS and 
PWM stimulate maximal proliferation of equine lymphocytes. PHA was 
added at a sub-optimal dose, one found to stimulate proliferation at 
approximately 50% of maximum, in order to increase the sensitivity of 
the PHA-treated cells to HCCM suppression. The three mitogen assays 
were run simultaneously with PBLs from three randomly chosen mares. 
PHA- and FWM-stimulated cultures were pulsed with H^-thyrtddine at 80 h 
and harvested at 96 h. LPS-stimulated cultures were pulsed at 96 h and 
harvested at 112 h since we found LPS-treated cells require more time 
to achieve their maximal proliferative response.
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Figure 8. Serial dilutions of PHA were tested in an equine 
lymphocyte proliferation assay to determine the PHA 
concentrations required to induce optimal and sub-optimal 
proliferative responses in our assay system. Data represent 
average cpm — SEM for three equine lymphocyte populations.
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Temporal Effect of HCCM. To determine the stage of cell 
activation with which HCCM-SF interferes, HCCM I was supplemented to 
lymphocyte cultures 0, 24 and 48 h following EWM stimulation of cells. 
The lymphocyte proliferation assay was prepared as previously 
described using lymphocytes from three randanly chosen mares. On the 
96-well plate, triplicate rows were designated, Time 0, Time 24 and 
Time 48. HCCM I was serially diluted in RFMI+ to three final 
concentrations of 480, 240 and 120 (ll/ml. Each of the Time 0 rows were 
supplemented with a different dilution of HCCM I (25 (ll/well). After 
24 h incubation, each of the three Time 24 rows received 25 (ll/well of 
the same three HCCM I dilutions. At 48 h the three Time 48 rows were 
similarly supplemented. At each treatment period, those wells not 
receiving HCCM I received 25 (ll RFMI+ such that final volume in all 
wells was 150 |ll. FWM was supplemented to all tut non-stimulated 
control wells at Time 0. All wells were pulsed at 100 h and harvested 
at 116 h. This experiment was carried out twice with a total of six 
PEL populations, and data from both experiments were pooled for 
statistical analysis.
Cells were treated with HCCM II prior to mitogen stimulation to 
determine if HCCM-treated lymphocytes are permanently suppressed. PBLs 
from two mares were prepared as described for the lymphocyte 
proliferation assays. The pre-stimulated cultures consisted of four 
treatments set up in sterile cryovials as follows: 1) NOn-stimulated
- 150 J1.1 cells + 450 |il RPMI+ 2) Control - 300 (ll cells + 900 (ll 
RPMI+ 3) HCCM 10 - 120 (ll HCCM II + 300 (ll cells + 780 (ll RFMI+ and 
4) HCCM 5 - 60 (ll HCCM II + 300 (ll cells + 840 (ll RTMI+. Vials were 
vortexed and incubated with loosened caps for 24 h. At the end of
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incubation, cells were washed twice in RFMI+ (400 x g; 10 min) and 
resuspended at 2 x 10® cells/ml. Cells from each pre-stimulated 
culture were pipetted into wells (50 (ll/well) and were treated with 25 
^1 REMI+ containing 0 [ll (pre-treated only cells), 5 [ll (pre/post­
treated 5 ) or 10 [ll (pre/post-treated 10) HCCM II. FWM was added to 
all hut non-stimulated control wells at this time. Assay was completed 
as previously described.
Equine Lymphocyte Supernatant Supplementation. Equine
PBMC supernatant (PEMCS) was generated fcy combining PBMEs from three 
mares, diluting cells in RFMI+ to a concentration of 5 x 10®/ml (10 ml 
total) in a tissue culture flask and adding 150 [ll PHA. After 6 h 
incubation, the cell suspension was pipetted into a 15 ml centrifuge 
tube and centrifuged (400 x g; 10 min). Medium was discarded and cells 
resuspended in 10 ml fresh RFMI+. Cultures were then incubated for 18
h, cells were again centrifuged (600 x g; 10 min) and PEMCS was
obtained. Control medium consisted of 10 ml of the same RPMI+
incubated for 18 h in a tissue culture flask. The PEM2S assay was
prepared with three lymphocyte populations. Two 96-well plates were 
set-up with serial dilutions of HCCM II (10 to .625 [ll/well). Cells
were added to wells (1 x 10® /well), and FWM was added to all but non- 
stimulated control wells. All wells of one plate received 50 [ll PEMCS 
while all wells of the second plate received 50 [ll CM. After 24 h of 
culture, wells received another 40 [ll of their respective medium
bringing total well volume to 150 [ll. The assay was completed as
previously described.
IL-2 Supplementation. The effect of supplementing HCCM- 
treated equine lymphocytes with recombinant human interleukin-2 (rIL-
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2; Cetus Corp., Emeryville, CA) was examined in two assays designed 
to determine if supplementation of rIL-2 to BCCM-treated lymphocytes 
would override the suppressive effect of HCCM. PBLs from three mares 
were used. In the first experiment, two sets of quadruplicate wells of 
each PEL population were supplemented with 3, 6, 12 and 24 p.1 of HCCM 
I. One set of each quadruplicate pair also received rIL-2 (200 U/ml). 
PHA (.125 fil/well) was added to all wells, cells were pulsed at 80 h 
and harvested at 96 h.
In the second experiment, HCCM II was diluted in RRyH-s- to 600 
|il/ml and supplemented to cultures in 25 |il volumes. Cell 
proliferation was stimulated with a sub-optimal dose of PHA (.125 
l^l/well). Serial dilutions of rIL-2 (50 to .78 U/ml) were also 
supplemented to cultures. To serve as a negative control, non- 
stimulated cells were similarly supplemented with rIL-2. The positive 
control consisted of cells, PHA and rIL-2, but no HCCM. Cultures were 
pulsed at 80 h and harvested at 96 h.
CTLL-2 Cells. tftilike resting lynphocytes, CTLL-2 cells 
continuously express the high affinity IL-2R complex, and the addition 
of small concentrations of IL-2 will immediately stimulate these cells 
to proliferate, while a deficiency of IL-2 will lead to their rapid 
demise (Gillis, 1978). To better understand the effect of HCCM on IL- 
2R function, fractionated HCCM II was added to CTLL-2 cell cultures. 
Triplicate wells of a 96-well plate were prepared with seven serial 
dilutions of rIL-2 (50 to .78 U/ml) to serve as a standard. In each of 
the following rows, rIL-2 was added to triplicate wells at 
concentrations identical to those in dilutions 3-6 of the standard 
(12.5 to 1.56 U/ml). Each of these rows also received 50 pl/well of
93
one of the two diluted fractions of HCCM II or CM. The standard wells 
received 50 jxl REMI+. CTLL-2 cells were added to all wells (2,000 
cells in 50 |il) and cultures were incubated for 24 h before cells were 
pulsed with ^h-thymidine (1 jiCi/well). Cultures were harvested 4 h 
after pulsing and radioactivity was determined by liquid scintillation 
counting.
Murine Splenocytes. Mouse splenocytes were obtained from 
spleen homogenate by Ficoll-gradient centrifugation and interface 
cells were recovered. Cells were rinsed twice with HBSS and 
resuspended in RIMI+ at 7 x 10^  cells/ml. Splenocytes were added to 
two 96-well plates in 25 p.1 volumes and were stimulated by the 
addition of 50 fll of FWM, PHA or Con A (5, 2.5 and 5 Jig/ml,
respectively). Fractionated HCCM II was supplemented to treated wells 
of one plate (20 (Xl/well), while stimulated control wells received 20 
(i,l of each CM fraction. Cells were pulsed at 88 h and harvested at 100 
h.
FACS Analysis. FACS analysis was used to determine the effect 
of HCCM II on proliferation of specific lymphocyte subsets. HCCM- 
treated cell populations were compared to non-treated cells using 
three antibodies to different equine lymphocyte markers. Antibodies 
were, the monoclonal antibodies (mAb) HT23A and HT14A (pan T and T 
suppressor cell subset antibodies, respectively; VMRD, Pullman, WA), 
and an FITC-conjugated polyclonal goat anti-equine IgG antibody (B 
cell antibody). The conjugate for the mAbs was an FITC-conjugated goat 
anti-mouse IgG antibody (VMRD, Pullman, WA). Two equine PEL 
populations were analyzed. For each population, five tissue culture 
flasks were prepared as follows: 1) Control - 4 ml RPMI+ 2) PHA -
6.25 |ll PHA + 4 ml RRH+ 3) FWM - 20 |Xl + 4 ml RPMI+ 4) PHA+ -
6.25 |ll PHA + 500 |ll HCCM II + 3.5 ml RBMI+ 5) FWM+ - 20 |ll PWM + 500 
|ll HCCM II + 3.5 ml RTMI+. To each flask, 1 ml of cells suspended in 
RPMI+ at 5 x 1q6 cells/ml was added. Flasks were incubated for 96 h 
and, using a hemacytometer, cell concentration was determined at the 
end of culture. The cell suspension in each flask was divided into 
five sterile tubes (1 ml/tube). Tubes were labeled as: 
autofluorescent control, FITC control, mAb HT23A, mAb HT14A and IgG- 
FITC. Cells were pelleted (400 x g; 10 min) and medium was decanted. 
Cells were rinsed with 3 ml volumes of PBS and decanted again. The 
monoclonal antibodies, HT23A and HT14A, were diluted 1:1000 in PBS 
supplemented with 10% goat serum (PBS-GS). The polyclonal goat anti- 
equine IgG-FITC and goat anti-mouse IgG-FITC antibodies were diluted 
1:400 in PBS-GS. Diluted antibodies were added to appropriate tubes 
(50 |ll/tube) while autofluorescent and FITC controls received 50 |ll 
cold PBS-GS. Tubes were vortexed and incubated on ice for 1 h. All 
samples were washed with 3 ml volumes of ice cold PBS-GS. After 
decanting, 75 |ll cold 1% p-formaldehyde was added to IgG-FITC tubes to 
fix cells. Tubes were vortexed and stored at 4°C. All remaining tubes, 
except the autofluorescent controls, received 50 |ll of diluted goat 
anti-mouse IgG-FITC. Autofluorescent controls received 50 |il PBS-GS. 
After vortexing, cells were incubated on ice 1 h, then washed and 
fixed as described for cells in IgG-FITC tubes. Samples were stored at 
4°C for 48 h then diluted with 100 |il PBS-EDTA and analyzed on a FACS 
440 (Becton Dickinson, Mountain View, CA). For each sample, 10,000 
cells were analyzed for both fluorescence and light scatter using a 
Consort 40 analyzer (Becton Dickinson, Mountain View, CA). Gate
settings were determined based on autofluorescent and FITC controls to 
eliminate any non-specific and/or background fluorescence. Due to 
between-flask variation in cell concentration following the 96 h 
culture, data were recorded herein as average cell number/ml (final 
cell concentration in flask x % of 10,000 labeled) such that results 
for a specific cell population would not be biased by a change in the 
size of other cell subset populations. The two-dimensional scatter 
analysis was used to conpare blast cell populations between 
treatments. The percent blast cells was determined by comparing 
stimulated to non-stimulated FITC control sairples. Gates were set such 
that the windowed area contained the larger cells present only in the 
stimulated sairples. A window with the same gate settings was then 
applied to the HCCM-treated, stimulated sairples, and the percentage of 
cells (blast cells) in this area was recorded.
Statistical Analysis. Average cpn and percent of stimulated 
control values were calculated for triplicate or quadruplicate wells 
of proliferation assays. Statistical analysis was performed using data 
recorded as cpn if the stimulated control values were the same for the 
treatments being tested. If the stimulated control values differed 
between treatment groups, data were expressed and analyzed as % of 
stimulated control. Results, in the appropriate form for each assay, 
were analyzed in a factorial arrangement by AM3VA using the general 
linear model procedures of the SAS coirputer package (Luginbuhl et al., 
1985). All main effect interactions were tested (i.e. treatment or 
time x HCCM or rIL-2 dose). Between treatment groups and within 
treatment differences were determined by Tukey mean comparison tests. 
To further compare the effect of rIL-2 on HCCM-treated cells to that
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on non-treated cells, regression analysis was carried out with data in 
each of the two rIL-2 supplementation assays. Treatment curves were 
compared and tested for differences in intercepts, linear functions 
and quadratic functions, and insignificant terms were dropped from the 
model.
RESULTS
Mitogen Comparison. The effect of HCCM-SF on lymphocyte 
cultures differed (pc.Ol) depending on the mitogen used to stimulate 
lymphocyte proliferation (Table 6). The results of a 3 x 6 factorial 
arrangement AN3VA and Tukey mean comparisons showed that, compared to 
stimulated controls, the percent suppression of HCCM-treated cell 
proliferation was greater (p<.01) in FWM-stirnulated cultures than in 
LPS- and PHA-stimulated cultures. PHA-stimulated cells were suppressed 
(pc.Ol) by high concentrations of HCCM (10 and 20 (i.l/well), but LPS- 
stimulated cells were unaffected (p>.05) at all levels of HCCM (within 
mitogen Tukey mean comparisons).
Temporal Effect of HCCM. Suppressive activity of HCCM-SF 
decreased (pc.001) if HCCM I was supplemented to lymphocyte cultures 
after the start of stimulation (Fig. 9). Although still suppressive, 
HCCM added to cultures 24 h after the start of stimulation was less 
(pc.Ol) effective then if added at Time 0. By 48 h following cell 
stimulation, the addition of HCCM to the cultures resulted in only a 
slight decrease in proliferation, much less (pc.Ol) than that observed 
when HCCM was added at Time 24. There were no main effect interactions 
(p>.05).
Lymphocytes pre-treated with HCCM II exhibited the capacity to 
respond maximally to mitogen stimulation (Fig. 10). Proliferation of
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TABLE 6. Effect of HCCM II supplementation to 
mitogen-stimulated lymphocytes3 .
 ....... — ' . MiilrOffSlI— . —-.
 LESE   - ___EB2£___ __ESZtiEl—
Non-Stimulated 8,990 ± 322 5,657 ± 578 14,712 ± 843
HCCM (fil/well)
0 (Control) 21,184 ± 2,713 76,648 ± 18,131 77,111 ± 19,572
1.25 20,180 — 3,553 72,660 ± 17,789 63,138 ± 13,418*
2.5 19,446 ± 788 72,762 ± 16,364 43,365 ± 9,260*
5 18,799 ±1,420 68,037 ± 14,010 30,595 ± 5,274*
10 20,700 ±1,117 58,726 ± 13,552* 22,271 ± 2,677*
20 19,187 ± 682 48,905 ± 11,160* 12,155 ± 1,094*
aValues represent mean cpm ± SEM for three lymphocyte 
populations.
k cc*Different superscripts designate between mitogen 
differences in overall suppressor activity (p<.01) as 
determined by Tukey mean comparisons using data expressed as 
% of control. There was a significant mitogen x HCCM 
interaction (pc.Ol).
*Differs from control (p<.01); within mitogen Tukey mean 
comparisons.
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Figure 9. Effect of HCCM I supplementation to PWM- 
stimulated lymphocyte cultures at 0, 24 and 48 hours after 
the start of culture. Values represent mean % of 
stimulated control i SEM for between lymphocyte population 
variation (n=6). Different superscripts denote an overall 
difference in suppression between times (p<.01; Tukey mean 
comparisons). There were no significant interactions 
(p>.05) .
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Figure 10. Response to PWM-stimulation following pre­
incubation of cells with HCCM II. Values represent mean 
cpm i SEM for two lymphocyte populations. Compared to the 
stimulated control (no HCCM), there was no difference 
(p>.05) in the proliferative responses of HCCM I pre­
treated cells, while the responses of pre/post-treated 
cells were suppressed (pc.Ol). Different superscripts 
denote differences in ^H-thymidine incorporation (pc.Ol; 
Tukey mean comparisons).
100
cultures pre-treated with 5 or 10 jXl HCCM/well did not differ (p>.05) 
from that of the stimulated control. However, the proliferative 
response of pre-treated cells to which 5 and 10 (Xl/well HCCM was again 
added during mitogen stimulation (pre/post-treated), was much less 
(pc.Ol) than that of both the pre-treated only cells and the 
stimulated control.
Equine Cell Supernatant and IL-2 Supplementation. FHA- 
stimulated PEMC supernatant was added to HCCM II-treated equine 
lymphocytes in an atterrpt to augment their proliferative response to 
EWM (Fig. 11), but compared to proliferation in control medium- 
supplemented cultures, there was no difference (p>.05). The addition 
of an extremely high concentration of rIL-2 (200 U/ml) to HCCM I- 
treated cells did not override the suppressive activity of HCCM I 
(Fig. 12). Although proliferation in cultures supplemented with rIL-2 
was greater (pc.Ol) than that in cultures without rIL-2, a dose- 
dependent decrease in proliferation with the addition of HCCM was 
observed even in cultures with 200 U/ml of rIL-2 (pc.Ol). Furthermore, 
results from the regression analysis showed that both treatment curves 
were linear with the same slope (p>.05) and only the intercepts were 
different (pc.Ol). Similarly, in Figure 13, regression analysis was 
used to determine that the slopes of the two treatment curves, PHA and 
PHA + HCCM, were linear and did not differ (p>.05). Again, only the 
intercepts were different (pc.Ol). The results of the 3 x 7  factorial 
ANOVA and Tukey mean comparisons showed that overall proliferation in 
HCCM II-treated cultures was less (pc.Ol) than that in PHA control 
cultures, but greater (pc.Ol) than that in non-stimulated cultures.
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Figure 11. Effect of PHA-stimulated equine PEMC supernatant 
supplementation to HCCM II-treated, PWM-stimulated lynphocytes. Data 
represent mean % of control — SEM for between lynphocyte population 
variation (n=3). Proliferation of cells supplemented with equine PBL 
supernatant did not differ (p>.05) from that of cells receiving 
control medium.
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Figure 12. Effect of human recombinant IL-2 supplementation (200 
U/ml) on proliferation of HCCM I-treated, PHA-stimulated equine 
PBLs. Data represent mean % of control (no HCCM or rIL-2 added) — 
SEM for between lymphocyte population variation (n=3). In both rIL-2 
supplemented and non-supplemented cultures, cell proliferation 
decreased (pc.Ol) with the addition of HCCM I. Different 
superscripts designate within treatment differences (a-c and a'-e" 
for within IL-2 and no IL-2 treatments, respectively; pc.Ol; Tukey). 
There was no treatment x HCCM interaction (p>.05) . Although the 
intercepts of the two treatment curves were different (pc.Ol), the 
linear slopes of the two curves did not differ (p>.05; ANOR; r2=.84).
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Figure 13. Effect of rIL-2 supplementation to non- 
stimulated, PHA-stimulated and PHA-stimulated + HCCM II- 
treated cell cultures. Data represent mean cpm — SEM for 
between lymphocyte population variation (n=3). rIL-2 
supplementation increased (pc.Ol) proliferation of cells 
within each treatment. Different superscripts denote 
between treatment differences (pc.Ol) in overall ^H- 
thymidine incorporation as determined by Tukey mean 
comparisons. While the intercepts of all three treatment 
curves differ (pc.Ol), the linear slopes of the PHA and 
PHA + HCCM curves are the same (p>.05; ANOR; r2=.73).
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CTLL-2 Cells and Murine Splenocytes. CTLL-2 cell 
proliferation in response to exogenous rIL-2 was not affected by the 
addition of the >100,000 MW fraction of HCCM, or the two fractions of 
CM (Table 7). However, the <100,000 MW fraction of HCCM did inhibit 
CTLL-2 proliferation (p<.01). While there was no treatment x rIL-2 
interaction (p>.05), only in the standard did a decrease in rIL-2 
result in a significant decrease in cell proliferation (p<.05). HCCM- 
SF appeared to be effective at suppressing PWM-stimulated murine 
splenocytes as incorporation of thymidine was less (px.01) in 
cultures treated with the >100,000 MW HCCM fraction than that in 
cultures treated with the > 100,000 MW CM fraction. However, there 
were no differences in proliferation between treatments within ConA or 
PHA (p>.05).
FACS Analysis. Data from the FACS analysis are recorded in 
Table 8. Because of the 96 h culture period prior to cell labeling and 
fixing, the cell concentration in each flask differed from the initial 
1 x 10 /^ml, with there being a decrease in cell number in the control 
flask and an increase in the mitogen-stimulated flasks. For this 
reason, the data are presented as final cell numbers/ml. Relative to 
non-stimulated controls, there was an increase in total T cells with 
both PHA and EVJM stimulation (+36,000 and +11,000 cells/ml, 
respectively). However, a more exaggerated increase in B cells was 
observed with both mitogens (+238,000 and +236,000 cells/ml, 
respectively). The addition of HCCM to PHA-stimulated cells resulted 
in a decrease of 66,000 T and 20,000 B cells/ml when compared to PHA- 
stimulated cells without HCCM. When HCCM was supplemented to PVM- 
stimulated cells, again, a decrease in T cells occurred (-19,000
TABLE 7. Effect of fractionated HCCM II and CM on CTLL-2 cells and murine splenocytes.
HCQMg__________  CMa
Standard <100c >100d <100d >100d
CTLL-2 cells13 
rL-2 (U/ml)
12.5 13.41 ± .45 6.28 ± 1.08 13.44 ± 1.52 10.45 ± .96 11.55 ± .17
6.25 13.48 ± .66 6.69 — .19 13.68 ± .69 13.03 ± .51 13.89 ± .68
3.125 13.42 ± .51 6.49 ± .42 13.38 ± .77 10.34 ± .88 12.23 ± .82
1.56 10.70 ± .48* 5.80 ± 1.14 11.21 ± .98 9.05 ± .86 11.98 ± .18
Mitogen <100 >100 <100 >100
PWM 28.20 ± 2.03 2.79 ± .52** 32.67 ± 4.96 40.28 ± 1.53
Con A 52.49 ± 7.21 26.45 ± 6.76 48.32 ± 8.35 36.59 ± 9.76
PHA 13.23 ± 1.78 16.50 ± 3.14 19.44 ± 4.71 18.24 ± 4.78
aHCCM II and CM were separated into two fractions, <100,000 MW and >100,000 MW as indicated by <10.0 and 
>100, respectively. Sample fractions were supplemented to cultures at 200 |ll/ml.
V^alues represent cpm — SEM (x 10”^ ) for triplicate wells.
D^ifferent superscripts designate between treatment differences in %-thymidine incorporation(p<.01; Tukey 
mean comparisons). There was no treatment x rIL-2 interaction (P>.05).
Values represent cpm — SEM (x 10“3) for quadruplicate wells.
*Designates significant difference as compared to other rIL-2 levels within column (p<.05; Tukey).
**Designates within row difference as compared to the similar MW fraction of CM (p<.05; Tukey) .
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TABLE 8. Fluorescence activated cell sorter analysisa .
Treatment*3
mAb
BT23A
(Total T) 
HT14A 
(T subset) 
IgG-FITC
(B cells)
Control
670 ± 55 
77 ± 11 
191 ± 59
Change in 
T cells (xlO3): 
Change in 
B cells (xlO3):
429 ± 10
+ 36 
+ 238
706 ± .5 640 ± 40
162 ± 16 150 ± 28
409 ± 17
- 30 
+ 218
PWM
681 ± 75 
111 ± 8 
427 ± 20
+ 11 
+ 236
PWM+
662 ± 32 
95 ± 23 
328 ± 8
-  8 
+ 137
aValues represent average number of antibody-labeled 
cells/ml — SEM (x 10-3) for two lymphocyte populations and 
the average change in cell number as compared to the 
control.
^Culture treatments are: Control - no mitogen or HCCM; PHA
- PHA-stimulated; PHA+ - PHA-stimulated and HCCM II treated; 
PWM - PWM-stimulated; PWM+ - PWM-stimulated and HCCM II 
treated.
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cel Is/ml) and an even greater decrease in B cells was also observed 
(-99,000 cells/ml). The presence of HCCM in PHA- and PWM-stimulated 
cultures decreased the T suppressor cell subset by 12,000 and 16,000 
cells/ml, respectively, as compared to stimulated controls. All 
mitogen-stimulated cell populations contained a greater number of B 
cells than did the control cultures, tut the T cell population 
decreased below control culture levels when HCCM was supplemented to 
the stimulated cultures (-30,000 and -8,000). The change in the 
approximate number of blast cells detected by side and forward light 
scatter analysis correlated with what was observed with final cell 
concentration in the FACS cultures and with -^-thymidine uptake data 
from the lymphocyte proliferation assays (Fig. 14). Compared to PHA- 
and EWM-stimulated controls, the average percent blast cells in HCCM- 
treated cultures decreased from 42.8 to 25.8 and 42.2 to 8.9 %, 
respectively.
DISCUSSION
T lymphocytes are largely responsible for the actions of cell- 
mediated immunity. Allograft rejection is caused mainly by T cells, 
although antibodies produced by B cells can also play an important 
role. The early developing fetus and the protective placental tissue 
surrounding it, express antigens that are foreign to the mother 
(Chatter j ee-Hasrouni and Lala, 1979; Jenkinson and Owen 1980; 
Billington and Burrows, 1986; Zuckermann and Head, 1986; Allen et al., 
1987). During successful pregnancies, fetal antigens do not initiate a 
cell-mediated rejection response, even though immune cells are present 
at the feto-matemal interface (Beer et al., 1975). An 
immunosuppressive substance (HCCM-SF) produced by the conceptus and
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Figure 14. Two-dimensional scatter analysis with side 
and forward light scatter parameters was used to examine 
the effect of HCCM on cell blastogenesis. The blast cell 
populations in HCCM-treated and non-HCCM-treated, mitogen- 
stimulated cultures were compared. Gate settings were 
adjusted by comparing the mitogen-stimulated control to the 
non-stimulated control, such that the window contained the 
blast cells present only in the stimulated cell population. 
The same settings were then applied to the 2-D scatter plot 
of the HCCM-treated cell population.
A. PWM-stimulated, HCCM-treated cell population (PWM+) of 
sample #384. The same window used in A was used to 
determine the percent blast cells (5.2%).
B. PWM-stimulated cell population (PWM) of sample #384. 
Window contains the larger cells (blast cells; 33.3%) that 
were absent from the non-stimulated cell population.
!
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acting on the T cells mar/ be inhibiting the T cell response to fetal 
antigens, thereby interfering with the otherwise eminent allograft 
rejection response. Likewise, this localized T cell suppression could 
also affect B cell proliferation, resulting in a reduction in antibody 
production at the site of implantation. Maternal systemic immune 
response, awary from localized HCCM-SF, would be unaffected. This 
hypothesis would explain why immune function of pregnant females is 
not compromised and anti-fetal antibodies are found in maternal 
circulation of 90% of normal equine pregnancies (Allen et al., 1987), 
yet the conceptus remains unharmed.
Through the use of PHA, a potent T cell stimulator, FWM, a T 
cell-dependent B cell stimulator and LPS, a T cell-independent B cell 
stimulator (Sharon, 1983; Jelinek and Lipsky, 1987), we obtained 
evidence indicating that the T cell population is directly affected fcy 
HCCM-SF. Possibly due to the potent stimulatory effect of PHA on T 
cells, relatively high concentrations (10-20%) of HCCM were required 
before a decrease in cell proliferation was observed. Supporting 
evidence for the suppression of T cells by HCCM was provided by the 
FACS analysis results which show the presence of HCCM decreased the T 
cell population by 66,000 cells/ml as compared to PHA-stimulated 
control cultures. While PHA-stimulation caused a dramatic increase in 
the B cell population compared to the control, there was only a 
minimal decrease of B cells when HCCM was also present in the culture. 
In contrast to PHA-stimulated cultures, PWM-stimulated cells appeared 
to be highly vulnerable to HCCM suppression as indicated by a rapid 
decline in their proliferative response at very low HCCM 
concentrations. The FACS data indicated that with PWM-stimulation
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there was only a minimal difference between T cell populations of 
HCCM-treated and non-treated cultures, but a dramatic decrease in B 
cell number. Because B cell proliferation depends on T cell-derived 
lymphokines (Howard and Paul, 1983), HCCM suppression of T cells would 
inhibit the production of T cell factors, thereby indirectly 
affecting the B cell population. Since FWM is a weak T cell 
stimulator, the loss of even a small portion of T cells may decrease 
lynphokine production to such low concentrations that a severe 
reduction of B cell proliferation, as that observed with the FACS 
analysis, results. The hypothesis that HCCM does not act directly on B 
cells is further supported by the fact that HCCM is ineffective at 
suppressing proliferation of cultures stimulated with LPS. As LPS acts 
on B cells without a requirement for T cells, the effect of HCCM on 
the T cell population does not alter the B cell response to LPS. The 
overall effect of HCCM-SF on mitogen-stimulated blastogenesis is most 
visually obvious in the FACS two-dimensional scatter analysis. Since 
light scatter parameters allow the sorting of cells by size and 
density, the blast cells can be identified. The two-dimensional 
scatter plot quite effectively demonstrates the decrease in blast 
cells when HCCM is present in the culture.
The process from initial lymphocyte stimulation to actual cell 
proliferation involves critical intermediate events. Mitogens will 
initiate cell activation within the first 6 h of culture and 
lynphokine production follows (Weiss et al., 1987). Peak levels of 
lymphokines are produced 24 to 48 h after initial stimulation, but 
after 24 h, there is an increased expression of lynphokine receptors 
and the cells begin to use the lymphokines produced (Altman et al.,
Ill
1990). The lyirphokine-receptor interaction acts as a secondary 
stimulus for promoting activated cell proliferation. Both B and T 
lyirphocytes require T cell derived lymphokines such as IL-4 and IL-2, 
respectively. Therefore, if T cell activation or T cell production of 
lynphokines is inhibited, both B and T cell proliferation will be 
suppressed. Data from experiments relating to the temporal effect of 
HCCM on stimulated lyirphocytes support the hypothesis that HCCM 
inhibits lynphokine production and/or lynphokine receptor expression 
fcy T cells. HCCM is largely ineffective at suppressing cell 
proliferation if added 48 h after the start of stimulation. Since most 
cells have received both primary (mitogen) and secondary (lynphokine) 
stimulation at 48 h, these results indicate that HCCM-SF must 
interfere with these initial events and that it does not affect the 
later events involved with proliferation. Treating cells with HCCM 24 
h after the start of stimulation allowed the cells time to become 
activated fcy mitogen and to begin producing lyrrphokines, however, few 
of the cells had teen fully stimulated fcy the secondary lyirphokine- 
receptor interaction prior to HCCM treatment, and thus, the suppressor 
factor was effective.
Although little is known afcout how HCCM-SF acts on the cells, we 
have shown that pre-treatment of cells for 24 h with HCCM, followed by 
thorough rinsing, resulted in a cell population with full 
proliferative capacity when subsequently stimulated with mitogen. 
These data demonstrate many important characteristics of HCCM-SF. The 
factor is obviously not cytotoxic and exhibits only a transient effect 
on lymphocyte proliferation. Furthermore, the fact that HCCM treatment 
does not exhibit any long-term effects on a cell population's
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responsiveness, indicates that HCCM suppression is not mediated 
through T suppressor cell recruitment and/or activation. The FACS data 
support this conclusion by demonstrating a decreased number of T 
suppressor cells in cultures treated with HCCM. Because
proliferation of T lyirphocytes depends largely on their ability to 
produce and respond to IL-2, an efficient mechanism for suppressing 
these cells would be an inhibition of IL-2 production. There is in 
vivo evidence that administration of antibodies to IL-2 can extend 
allograft acceptance (Kirkman et al., 1985). Furthermore, 
administration of a high IL-2 dose to mice terminates a successful 
ongoing pregnancy (Lala et al., 1990). It seems IL-2 plays an integral 
role in allograft acceptance and rejection. Considering this 
association, it is not surprising that many studies have been carried 
out examining the effect of conceptus or uterine derived suppressor 
factors on lymphocyte production of IL-2 and/or expression of IL-2R. 
In many cases the data indicate that a relationship exists between 
these suppressor factors and IL-2 production (Segerson, 1988; Saito et 
al., 1990; Segerson and Gunsett, 1990; Segerson and Libty, 1990). 
Since HCCM-SF acts on T lyirphocytes and is only effective if present 
during the first 48 h of stimulation, it is possible the suppressor 
mechanism is mediated through the inhibition of IL-2 production. Our 
initial attempt to overcome a potential deficiency of IL-2 in HCCM- 
treated cultures fcy supplementing the cultures with PEMCS, was not 
particularly effective. Since it has been shown that stimulated equine 
lymphocyte supernatant contains the lymphokines required to support 
IL-2 dependent cell responses (Magnuson et al., 1984), we expected our 
PBMCS to contain high levels of IL-2, but our attempt to quantify this
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IL-2 was unsuccessful because the murine-derived CTLL-2 cells did not 
respond to equine PBMCS.
Our attempt to override the suppressive activity of HCCM by 
supplementing cultures with rIL-2 at 200 U/ml also proved 
unsuccessful. The addition of this high concentration of rIL-2 should 
compensate for an IL-2 deficiency in the cultures. The fact that HCCM 
suppressed proliferation of cells, even in the presence of an over­
abundance of rIL-2, demonstrates that HCCM suppression is not solely a 
result of deficient IL-2 production. Furthermore, because the slopes 
of the treatment curves in Figure 12 are the same, we can conclude 
that the suppressive activity of HCCM remains the same, regardless of 
the IL-2 concentration in the culture. Because a sub-optimal dose of 
PHA was used in the cultures, an IL-2 deficiency existed and the 
enhanced proliferation observed in the rIL-2 supplemented cultures 
simply reflects the effect of sufficient IL-2 on those cells not 
suppressed fcy HCCM-SF. One explanation for the inability of rIL-2 to 
overcane HCCM-induced suppression is that HCCM-SF is inhibiting IL-2R 
expression, rendering some cells incapable of responding to the 
exogenous rIL-2. Alternatively, HCCM-SF may be acting fcy interfering 
with the necessary IL-2/IL-2R interactions. Finally, as very high 
levels of IL-2 will activate T and B cells via the intermediate 
affinity p-75 £ receptor (Cosman et al., 1987), it is possible the 
high concentration of rIL-2 supplemented to the cultures stimulated 
cells not expressing the high affinity IL-2R, thereby increasing 
proliferation in the HCCM-treated cultures.
Because CTLL-2 cells continuously express the high affinity IL- 
2R, they were used to test the hypothesis that HCCM-SF interferes with
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the ZL-2/IL-2R interaction. We found that only the <100,000 MW 
fraction of HCCM inhibits CTLL-2 cell proliferation, possibly due to 
hormones and/or interferons produced by the horse conceptus. More 
important, our data show that the >100,000 MW fraction of HCCM exerts 
no suppressive effect on the CTLL-2 cell response to rIL-2. The fact 
that murine splenocytes are suppressed if treated with 200 i^l/ml of 
the >100,000 MW fraction of HCCM (the same concentration used on the 
CTLL-2 cells), indicates that the ineffectiveness of HCCM on CTLL-2
cells is not simply due to species specificity of the suppressor
factor. These results suggest that HCCM-SF interferes with cellular
events prior to the expression of the high affinity IL-2R, but is not 
capable of suppressing cell proliferation following IL-2R expression. 
However, there does exist the possibility that the CTLL-2 cells differ 
significantly from T cells found in vivo, and thus may not be 
vulnerable to the suppressor activity of HCCM-SF.
Because HCCM-SF does not interfere with the IL-2/IL-2R 
interaction, we investigated the possibility that the high levels of 
exogenous rIL-2 activate T and B cells via the intermediate affinity 
p-75 £ receptor, thereby increasing proliferation in HCCM-treated 
cultures. In Figure 13 we show that with increasing rIL-2
concentrations, proliferation in non-stimulated cultures increased and 
then plateaued. The initial increase could be at tribated to the effect 
of high rIL-2 levels on the p-75 £ receptors. A rIL-2 associated 
increase in proliferation was also observed in cultures of both PHA- 
stimulated treatment groups because sub-optimal PHA was used, and 
thus, IL-2 was deficient until cultures were supplemented with rIL-2. 
If rIL-2 supplementation increased proliferation of HCCM-treated
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cultures only fcy activating cells via intermediate affinity receptors, 
a dose-dependent increase in proliferation would not result, and the 
slope of the PHA + HCCM treatment curve would be the same as that of 
the non-stimulated treatment curve. In contrast, the slope of the PHA 
+ HCCM curve was the same as that of the PHA curve, indicating 
proliferation was mediated via high affinity IL-2R on activated cells. 
However, it is important to note that the relative difference in 
proliferation between these two treatments remained constant at all 
levels of rIL-2, indicating that, while the effect of rIL-2 was 
similar in both treatments, there were fewer cells capable of 
responding to the rIL-2 in the PHA + HCCM cultures. The results from 
Figures 12 and 13 and the CTLL-2 assay suggest that, in cultures 
treated with HCCM, there exist fewer IL-2R expressing cells capable of 
responding to rIL-2. These results are in agreement with reports fcy 
Bulmer and Johnson (1986) who found that T lymphocytes in human 
decidua do not express IL-2Rs. Still, there seems to exist sane 
activated cells that do express the IL-2R and exogenous rIL-2 enhances 
their proliferative response. It is not known whether IL-2R expression 
is inhibited fcy HCCM-SF directly or indirectly through the 
interference of HCCM-SF with other early events in T cell activation. 
T cell expression of the high affinity IL-2R requires multiple 
signals, including antigenic stimulation in the context of self-major 
histoccnpatibility antigens and the macrophage product IL-1 (Gery et 
al., 1972). Our use of mitogens to stimulate the cells ofcrviated the 
need for anitigenic stimulation, thus precluding the possibility that 
suppression involved an alteration in the function of the T cell 
antigen-specific receptor. We cannot rule out the possibility that
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suppression results from an alteration in the production or function 
of H.-1. Such a mechanism of suppression has been suggested for a 
human placental protein (Pockley and Bolton, 1989).
If HCCM-SF is interfering with IL-2R expression, it is possible 
that it is actually acting directly on both B and T cells. FWM- 
stimulated B cells express the IL-2R (Waldmann et al., 1984) while 
LPS-stimulated B cells do not (Leibson et al., 1981; Robb et al., 
1981), thereby indicating that IL-2Rs play an important role in EMI- 
stimulated B cell proliferation. HCCM-SF inhibition of IL-2R 
expression may imply a mechanism acting directly on B cells and 
indirectly, through T cell suppression, resulting in the loss of B 
cells and lack of ^H-tbymidine incorporation in PWM-stimulated, HCCM- 
treated cultures. Furthermore, as neither IL-2Rs nor T cells seem to 
be involved with LPS-stimulated B cell proliferation, it would follow 
that we would not observe suppression of such cultures with HCCM 
supplementation.
In a previous study, we reported the production of an 
immunosuppressive factor produced by Day 10 - Day 26 horse conceptuses 
(Roth et al., 1990). In that study, the conceptus cultures were 
carried out as those described herein for obtaining HCCM I. In this 
study, we cultured Day 20 conceptuses in medium without PCS, thereby 
obtaining HCCM II. The immunosuppressive characteristics of HCCM I and 
II appear to be similar, indicating that supplementation of FCS to the 
culture medium is not required by horse conceptus tissue for the 
production of the suppressor factor. HCCM-SF is >100,000 MW, 
suppresses proliferation of T lymphocytes and seams to indirectly 
suppress B lymphocytes. This non-cytotoxic suppressor factor is
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effective only if present during the early stages of lymphocyte 
activation and its effect on cells is completely reversible. It is 
important that the suppressor factor is not cytotoxic, as excessive 
cell death at the feto-matemal interface could lead to the release of 
lysozymes and interferons resulting in an unhealthy environment for 
placental development. Furthermore, the lack of toxicity and the 
transient suppressive effect of HCCM, ensures that its effect is 
localized and that the systemic maternal immune system is not down- 
regulated or detrimentally altered by HCCM-SF during pregnancy. HCCM 
suppression is highly dependent on the suppressor factor's ability to 
act on the cells during the early stages of activation and could 
explain why such factors are produced by horse embryos as early as Day 
10 (Roth et al., 1990). At this stage of development, the embryo is 
still highly mobile and is enclosed in the protective embryonic 
capsule. By day 15, when uterine migration ceases (Ginther, 1986) and 
the conceptus becomes more intimately associated with maternal tissue, 
the concentration of suppressor factor in utero may be high enough 
that local maternal T cell quiescence is maintained. Because of its 
suppressive effect on T cells, HCCM-SF could play a role in preventing 
lynphocyte destruction of endometrial cups prior to day 120 of 
pregnancy. Our results suggest that the factor suppresses cell 
proliferation by preventing IL-2R expression. In view of the fact that 
T cells are largely responsible for allograft rejection, and the IL- 
2/IL-2R interaction is a prerequisite for complete T cell activation, 
we hypothesize that this suppressor factor, by inhibiting IL-2R 
expression, disrupts the T cell-mediated allograft rejection that 
might otherwise terminate pregnancy.
SUMMARY AMD CONCLUSIONS
One aspect of the fetal-maternal immunological relationship was 
studied. In our initial experiment, immunosuppressive activity- 
derived from sheep, goat and sheep x goat hybrid trophoblast tissue 
obtained at day 20 of gestation was examined. Medium conditioned by- 
all three types of trophoblast similarly suppressed both sheep and 
goat lyirphocytes. The results from this study indicate that 
suppressor factors are secreted fcy hybrid trophoblast at day 20 of 
gestation and these factors do not differ from those of sheep and goat 
trophoblast tissue in their ability to suppress FWM-stimulated 
lymphocytes.
All subsequent studies, in which conceptus-derived 
immunosuppressor activity was studied in greater detail, were carried 
out with the horse conceptus. The equine model was chosen because it 
is unique in that hybrid and interspecific pregnancies are successful, 
yet the characteristic events involved in placental formation and 
subsequent function differ depending on the particular type of 
pregnancy. Prior to this study, horse conceptus immunosuppressor 
factors had not been described. Therefore, we first identified the 
presence of a non-antigen specific immunosuppressive factor produced 
fcy horse embryos from day 9 through at least day 26 of development. 
While we refer to this factor in the singular tense, it is quite 
possible there is more than one factor responsible for the 
immunosuppressive activity.
Initially we determined that the suppressor factor is >30,000 MW 
and extremely stabile under harsh treatments. EXie to its size and 
stability, the factor does not appear to be a hormone or interferon.
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HCCM-SF exhibits its suppressive effect in a similar manner on donkey 
and horse lyirphocytes, yet is less effective on the less-related goat 
lyirphocytes. These results differ from those of the preliminary 
sheep, goat, hybrid study where the suppressor activity in the 
conditioned medium from these species did not exhibit species- 
specificity. This difference may simply reflect the increased 
sensitivity of the equine assay relative to that of the sheep/goat 
assay.
In the third experiment, the effect of indomethacin on the 
production of the suppressor factor was examined. Horse trophoblast 
tissue from 21 day-old conceptuses was cultured for 24 h in the 
presence or absence of 10“4 M indome thacin. The concentration of PGE2 
and the suppressive activity of the conditioned mediums were 
determined. While PGE2 was reduced ky 91%, the suppressive activity 
of the two mediums did not differ. Thus, in contrast to results from 
a number of studies with other species which have indicated the 
involvement of PGE2 in conceptus-derived suppressor activity, our data 
indicate that the horse trophoblast-derived immunosuppressor is not 
associated with prostaglandin production.
In our final series of experiments we examined the suppressive 
mechanism of HCCM-SF. Using microconcentrator centrifugation, we 
found that HCCM-SF is >100,000 MW. Results obtained from the FACS 
analysis in which we compared HCCM-SF-treated to non-treated 
lymphocyte cultures, indicated that HCCM-SF acts directly on T 
lyirphocytes and indirectly on B lyirphocytes. This conclusion was 
largely confirmed with results obtained from HCCM-SF-treated 
lymphocyte proliferation cultures in which mitogens with different
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specificities were used. In addition, we determined that this factor 
is not cytotoxic, affects cells during the early stages of activation 
and does not permanently suppress the lyirphocytes. These 
characteristics of HXM-SF are important for the following reasons: 
1) if cytotoxic, HXM-SF would cause excessive cell death at the 
fetal-maternal interface, likely resulting in an unhealthy environment 
for fetal development, 2) if the effect of HXM-SF was cytotoxic 
and/or irreversible, it might detrimentally alter maternal systemic 
immunity and, 3) the fact that HXM-SF must affect cells prior to 
their complete activation could explain why HXM-SF is produced fcy 
embryos prior to the cessation of uterine migration and the initiation 
of implantation. Furthermore, we found that a high concentration of 
human rIL-2 could not override the suppressive effect of HXM-SF in 
lymphocyte cultures. However, IL-2R expressing CTLL-2 cells were not 
inhibited fcy HXM-SF. These results indicate that HXM-SF inhibits T 
cell expression of the IL-2R.
In summary, a high-molecular-weight (>100,000 MW) 
immunosuppressive factor is produced fcy early and late pre- 
implantation horse conceptuses. This factor is very stabile, is not 
cytotoxic and is not associated with PGE2. It effects T lymphocytes 
early during cell activation fcy inhibiting the expression of the IL-2R 
and, therefcy, may play a role in disrupting T cell-mediated allograft 
rejection that might otherwise terminate pregnancy. While no 
difference in sheep, goat and sheep x goat fcybrid trophoblast tissue- 
derived suppressor activity on sheep and goat lymphocytes was 
identified, HXM-SF did exhibit same degree of species-specificity. 
Together, these data indicate an important immunoregulatory role for
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soluble trophoblast-derived factors that may facilitate fetal 
allograft survival and that may also be associated with the success or 
failure of interspecies pregnancies. With this newly acquired 
knowledge about the effect of HCCM-SF on horse lyirphocytes, we can 
begin to examine similar factors and their effects on maternal 
lyirphocytes during interspecific and hybrid pregnancies to more 
accurately assess the role of these factors in fetal allograft 
protection.
Future Work
While a large body of information pertaining to HCCM-SF has been 
accumulated, a great deal remains unknown and is worthy of further 
investigation. The objectives of future studies might be to determine 
both the physical nature and the physiological activity of this 
factor(s). Column chromatography might prove to be a viable method 
for determining the actual size of HCCM-SF. Numerous techniques, such 
as charcoal extraction, lipid extraction, glycosidase digestion and 
dithiothreitol reduction, could potentially be used to biochemically 
define HCCM-SF. Although we have identified some of the effects of 
HCCM on lynphocytes, its mechanism of suppression is not yet fully 
understood. As IL-1 plays a major role in lymphocyte activation, both 
the effect of HCCM on IL-1 production and the ability of exogenous IL- 
1 to overcane HCCM suppression should be investigated. Studies could 
also be carried out to examine the effect of HCCM on intracellular 
events during cell activation, such as Ca+ release. The results of 
such studies might lead to a more complete understanding of how 
lymphocyte quiescence is maintained in HCCM-treated cultures. It 
might also be possible to obtain more direct evidence of IL-2R
122
involvement in T lymphocyte suppression fcy using ^^I-rIL-2 and 
directly measuring IL-2R on HCCM-treated vs. non-treated cell 
populations.
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APPENDIX
In addition to the studies described in Chapters II - V, several 
experiments were carried out that were never published and/or fully 
completed. The information gained from these additional experiments, 
although sometimes inconclusive and/or preliminary, may be useful to 
those specifically interested in characterizing conceptus-derived 
immunosuppressive factors. Therefore, I have included in this 
appendix a brief summary describing the studies, the rationale behind 
them and the results.
While concluding that HCCM-SF is >100,000 MW and therefore not a 
steroid hormone, we questioned the possibility that hormones attached 
to larger molecules (carrier proteins) could remain in the retentate 
fraction during centricon centrifugation and thus, be active in the 
>100,000 MW fraction. RIAs were used to determine the concentration 
of progesterone and estrogen in HCCM, and to determine if the steroids 
were passing through the centricon membrane. A sample of HCCM was 
separated ly centricon centrifugation and each fraction (>100,000 and 
<100,000 MW) and an aliquot of unfractionated HCCM were analyzed. 
Results from the RIAs indicated that the concentrations of 
progesterone and total estrogen in the unfractionated sample of HCCM 
are much lower (2 to 7 ng/ml and 1 to 10 ng/ml, respectively) than 
those required for suppressing lymphocytes in proliferation assays. 
Furthermore, the fact that 75 to 100% of the hormones were identified 
in the <100,000 MW aliquot of the fractionated HCCM clearly indicated 
that the hormones were passing through the centricon membrane. These 
results support our conclusion that the suppressive activity of HCCM 
is not due to steroid hormones.
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In addition to the studies described in chapter III, two 
experiments designed to alter the immunosuppressive activity of HCCM 
were carried out. In the first experiment, the pH of HCCM (pH = 8.2) 
was altered fcy the addition of IN HCl or NaOH to become acidic (pH = 
2.0) or basic (pH = 12.0), respectively. The two samples were 
maintained at room terrperature for 1 hour, neutralized (pH = 8.0), 
fractionated through 10,000 MW exclusion centricons and tested for 
suppressive activity. While similarly treated CM exhibited no 
suppressive effect, both acid and base treated samples of HCCM 
retained significant suppressive activity. However, it is possible 
the activity was reduced from that of fresh HCCM. In a second 
experiment HCCM was subjected to protease digestion. Aliquots of HCCM 
and CM (800 pil; w/o FCS) were combined with 40 mg of protease beads 
and were rocked on a tube rocker for 24 hours at room terrperature. 
Following digestion, samples were fractionated with a 100,000 MW 
exclusion centricon and retentate volumes (>100,000 MW) were tested 
for suppressive activity. Protease-treated HCCM exhibited suppressive 
activity equal to that of non-treated HCCM.
The protein content in samples of HCCM lacking any exogenous 
protein source, was determined using a Bio Rad protein determination 
assay. Aliquots of HCCM from 20-day-old conceptuses (n=6; each 
cultured in 20 ml RHCE) were analyzed. The protein content ranged 
from .025 to .078 ng/ml with an average of .055 ng/ml.
Polyacrylamide gel electrophoresis was carried out with 
concentrated samples of HCCM (5X; n=6). Separating gels (both 7.5% 
and 10% acrylamide) were stained with coomassie blue. While numerous 
bands stained uniformly across all samples, there were no bands
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distinguishing proteins >100,000 MW on the gels. Furthermore, in 
lanes where only the >100,000 MW fraction of HCCM was applied, there 
were no distinct bands. However, there was evidence of staining at 
the top of the gel indicating the possible existence of high- 
nolecular-weight proteins that never entered the separating gel.
VITA
Terri Lynn Roth was bom to Julie and Bemie Roth on February 20, 
1964 in San Diego, California. She graduated as valedictorian of her 
class in 1982 from Foothill High School in Pleasanton, California. 
Following high school, she attended the University of California Davis 
where, in March 1986, she received her Bachelor of Science degree in 
Animal Science graduating with high honors. She remained at U.C. Davis 
following her acceptance into the Animal Science graduate program and 
received her Master of Science degree in June 1988. Terri then accepted 
a Board of Regents Fellowship at Louisiana State university where she 
has pursued a Doctor of Philosophy degree in Animal Science. Upon 
completion of this degree, Terri will accept a post-doctoral position at 
the National Zoo in Washington D.c. where she will use both her 
knowledge and training in an effort to enhance the propagation and 
survival of endangered species.
151
DOCTORAL EXAMINATION AND DISSERTATION REPORT
C andidate: Terri Lynn Roth
M ajor Field: Animal Science
Title of Dissertation: Conceptus-derived immunosuppressive factors and their role in fetal 
allograft protection.
Approved:
ajor Professor and Chairman
Dean of the Graduate School
E X A M IN IN G  C O M M ITT E E :
A
Date of Exam ination:
